Carl J Pepine

Carl J Pepine, M.D.

Professor Of Medicine

Department: MD-CARDIOLOGY
Business Phone: (352) 273-9082
Business Email: pepincj@medicine.ufl.edu

About Carl J Pepine

Carl J. Pepine, MD, is a doctor in the Division of Cardiovascular Medicine at the University of Florida College of Medicine. He graduated from the University of Pittsburgh in 1962 with his bachelor’s degree.

As he started medical school at Rutgers in New Jersey with his MD in 1966, Pepine stayed in the northeast for his internship at Allegheny General Hospital, a University of Pittsburgh affiliate. His two residencies were at Jefferson Medical College Hospital and Regional Naval Medical Center. He completed both fellowships in 1971 and became board certified in Internal Medicine and the subspeciality of Cardiovascular Disease.

He is currently a principal investigator of many NIH- and industry-funded research projects on cardiovascular disease in women, IHD, hypertension, heart failure, and cell-based therapy, with continuous peer-reviewed federal research funding (DoD, NIH, VA Merit) for over 40 years.

Pepine served as Chief of the UF Division of Cardiovascular Medicine from 1998–2008 and Chief of Cardiology, VA Medical Center, from 1978–1994. He has published more than 1,100 scientific articles, has edited 6 textbooks, and has been on the editorial boards of all major cardiovascular journals. He is the founding editor of Cardiology Today and Editor-in-Chief for American Heart Journal Plus: Cardiology Research and Practice. Pepine is currently the co-director of CTSI Multi-site Study Support Team at the National Center for Research.

Accomplishments

Wenger Award for Excellence in Medical research and Leadership
2019 · National Coalition for Women with Heart Disease
Bernadine Healy Leadership in Women’s Cardiovascular Disease Award
2018 · American College of Cardiology
Lifetime Achievement Award
2010 · University of Florida
Gifted Scientist Award
2009 · Florida Chapter, American College of Cardiology
Distinguished International Educator
2005 · University of Florida
President
2003-2004 · American College of Cardiology
Eminent Scholar Chair in Cardiovascular Research (UF)
2001-2008 · American Heart Association (AHA) – Suncoast Chapter, Inc.
Gifted Teacher Award
2001 · Florida Chapter, American College of Cardiology
Research Foundation Professorship Award
1999-2001 · University of Florida
Elected to Association of University Cardiologists (AUC)
1998 · Association of University Cardiologists
Theodore E. Woodward Award
1998 · American Clinical and Climatological Association (ACCA)
Paul Dudley White Award
1991 · Association of Military Surgeons of the United States
President
1986-1987 · Florida Chapter, Amercian College of Cardiology
Elected to the American Society for Clinical Investigation (ASCI)
1982 · American Society for Clinical Investigation
Outstanding Young Men of America
1972 · Outstanding Young Men of America

Teaching Profile

Courses Taught
2014
GMS6335 Tissue Engineering

Board Certifications

  • Cardiovascular Disease
    American Board of Internal Medicine
  • Diplomate
    American Board of Internal Medicine
  • Diplomate
    National Board of Medical Examiners

Clinical Profile

Specialties
  • Cardiology
Areas of Interest
  • Cardiomyopathy
  • Coronary heart disease
  • Essential hypertension

Research Profile

My career has focused on improving our understanding of mechanisms underlying ischemic heart disease (IHD) and related adverse outcomes. I have conducted extensive investigations in coronary artery disease (CAD), hypertension, treatment resistant hypertension, vascular biology, and therapeutic applications related to vascular dysfunction. My work has centered on how IHD becomes manifest with and without large coronary artery obstructive disease (CAD). Much of this work is concentrated in women with known or suspect IHD. A major goal of clinical research is development of actionable information of sufficient power to alter medical care and improve patient health by information obtained through performance of clinical trials. To this end, I conceived and led the first randomized controlled international mega-trial of blood pressure control for patients with CAD (INVEST). My experience also includes being a principal investigator (PI) in multiple NHLBI-funded projects [Women’s Ischemia Syndrome Evaluation (WISE), WISE-CVD, WISE HFpEF, MayWEST, Asymptomatic Cardiac Ischemia Pilot (ACIP), Psychophysiologic Interventions of Myocardial Ischemia (PIMI), Bypass Angioplasty Revascularization Investigation 2-Diabetes Trial (BARI2D), etc.] and many other industry-sponsored studies. More recently I have been working in cardiovascular recovery and regeneration with cell based therapies as a PI in the NHLBI Cardiovascular Cell Therapy Network (CCTRN)- 1 and 2, as well as studies funded by the the cell and gene biomedical industry.

Open Researcher and Contributor ID (ORCID)

0000-0002-6011-681X

Areas of Interest
  • Cardiovascular Cell Therapy
  • Heart Disease in Women
  • Heart Failure
  • Hypertension
  • Ischemic Heart Disease

Publications

2024
Initial Antihypertensive Prescribing in Relation to Blood Pressure Among Florida Medicaid and Medicare Recipients in the OneFlorida+ Research Consortium
Hypertension. 81(2) [DOI] 10.1161/hypertensionaha.123.21901.
2024
Single Nucleotide Polymorphisms in Coronary Microvascular Dysfunction
Journal of the American Heart Association. 13(4) [DOI] 10.1161/jaha.123.032137.
2023
An international perspective on low-dose aspirin for the primary prevention of myocardial infarction.
International journal of cardiology. 373:17-22 [DOI] 10.1016/j.ijcard.2022.11.036. [PMID] 36442672.
2023
ANOCA/INOCA/MINOCA: Open artery ischemia
American Heart Journal Plus: Cardiology Research and Practice. 26 [DOI] 10.1016/j.ahjo.2023.100260. [PMID] 37064505.
2023
Association of abnormal electrocardiography response on dobutamine stress echocardiogram with longer-term major adverse cardiovascular events in women with symptoms of ischemic heart disease.
Cardiovascular diagnosis and therapy. 13(6):948-955 [DOI] 10.21037/cdt-23-296. [PMID] 38162097.
2023
Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) project.
Frontiers in cardiovascular medicine. 10 [DOI] 10.3389/fcvm.2023.1155914. [PMID] 37324629.
2023
Circulating Biomarkers in Coronary Microvascular Dysfunction
Journal of the American Heart Association. 12(12) [DOI] 10.1161/jaha.122.029341.
2023
Clinically stable covid-19 patients presenting to acute unscheduled episodic care venues have increased risk of hospitalization: secondary analysis of a randomized control trial.
BMC infectious diseases. 23(1) [DOI] 10.1186/s12879-023-08295-9. [PMID] 37189091.
2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE.
American heart journal. 264:31-39 [DOI] 10.1016/j.ahj.2023.06.001. [PMID] 37290700.
2023
Dietary Composition, Angiographic Coronary Disease, and Cardiovascular Outcomes in the WISE Study (Women’s Ischemia Syndrome Evaluation)
Journal of Clinical Medicine. 12(24) [DOI] 10.3390/jcm12247762. [PMID] 38137831.
2023
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.
JAMA cardiology. 8(11):1061-1069 [DOI] 10.1001/jamacardio.2023.3364. [PMID] 37792369.
2023
Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week.
Journal of the American College of Cardiology. 81(5):505-514 [DOI] 10.1016/j.jacc.2022.08.814. [PMID] 36725179.
2023
EXACT Trial: Results of the Phase 1 Dose-Escalation Study
Circulation: Cardiovascular Interventions. 16(8) [DOI] 10.1161/circinterventions.123.012997.
2023
Fitness attenuates long-term cardiovascular outcomes in women with ischemic heart disease and metabolic syndrome.
American journal of preventive cardiology. 14 [DOI] 10.1016/j.ajpc.2023.100498. [PMID] 37181803.
2023
Heart and brain interactions: is small vessel disease a link?
European Heart Journal. 44(2):126-128 [DOI] 10.1093/eurheartj/ehac570.
2023
High‐throughput screening for prescribing cascades among real world statin initiators
Pharmacoepidemiology and Drug Safety. 32(7):773-782 [DOI] 10.1002/pds.5607.
2023
Host‐Microbiota Communication in Spontaneously Hypertensive Rats Generates Unique IgA‐Coated Gut Microbes
Journal of the American Heart Association. 12(4) [DOI] 10.1161/jaha.122.027918.
2023
Influence of Butyrate on Impaired Gene Expression in Colon from Patients with High Blood Pressure.
International journal of molecular sciences. 24(3) [DOI] 10.3390/ijms24032650. [PMID] 36768972.
2023
Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
Journal of the American Heart Association. 12(1) [DOI] 10.1161/jaha.122.026652.
2023
Left ventricular ejection fraction and long-term outcomes in women presenting with signs and symptoms of ischaemia.
Heart (British Cardiac Society). 109(21):1624-1630 [DOI] 10.1136/heartjnl-2023-322494. [PMID] 37316162.
2023
Long-Term Adverse Outcomes in Black Women With Ischemia and No Obstructive Coronary Artery Disease: A Study of the WISE (Women’s Ischemia Syndrome Evaluation) Cohort
Circulation. 147(7):617-619 [DOI] 10.1161/circulationaha.122.063466.
2023
Long-term Adverse Outcomes in Black Women With Obstructive Coronary Artery Disease: A Study of the Women’s Ischemia Syndrome Evaluation (WISE) Cohort.
The Canadian journal of cardiology. 39(11):1664-1666 [DOI] 10.1016/j.cjca.2023.08.010. [PMID] 37897475.
2023
Longitudinal cardiac remodeling in collegiate American football players as assessed by echocardiography during their collegiate career
Clinical Cardiology. 46(9):1090-1096 [DOI] 10.1002/clc.24121. [PMID] 37573574.
2023
Modifiable statin characteristics associated with potential statin‐related prescribing cascades
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 43(12):1307-1316 [DOI] 10.1002/phar.2883.
2023
Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline‐Based Chemotherapy
Journal of the American Heart Association. 12(10) [DOI] 10.1161/jaha.122.027981.
2023
Reprograming of transcriptional profile of colonic organoids from patients with high blood pressure by minocycline.
American heart journal plus : cardiology research and practice. 36 [DOI] 10.1016/j.ahjo.2023.100343. [PMID] 38222308.
2023
Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis
Hypertension. 80(11):2293-2302 [DOI] 10.1161/hypertensionaha.123.21496.
2023
Social Vulnerability Is Associated With Higher Rates of Hospitalizations and Amputations for Peripheral Arterial Disease.
The American journal of cardiology. 203:463-465 [DOI] 10.1016/j.amjcard.2023.07.063. [PMID] 37542956.
2023
Symptom Presentation among Women with Suspected Ischemia and No Obstructive Coronary Artery Disease (INOCA)
Journal of Clinical Medicine. 12(18) [DOI] 10.3390/jcm12185836. [PMID] 37762777.
2023
The CardiAMP Cell Therapy for Heart Failure trial.
Texas Heart Institute journal. 50(5) [DOI] 10.14503/THIJ-23-8242. [PMID] 37881037.
2022
Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis.
Frontiers in physiology. 13 [DOI] 10.3389/fphys.2022.909870. [PMID] 35812313.
2022
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
The lancet. Diabetes & endocrinology. 10(9):645-654 [DOI] 10.1016/S2213-8587(22)00172-3. [PMID] 35878651.
2022
Body weight and physical fitness in women with ischaemic heart disease: does physical fitness contribute to our understanding of the obesity paradox in women?
European journal of preventive cardiology. 29(12):1608-1614 [DOI] 10.1093/eurjpc/zwac046. [PMID] 35244151.
2022
Cold Pressor Testing and Sympathetic Nervous System Contribution to Ischemia with No Obstructive Coronary Artery Disease: Results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Project.
American heart journal plus : cardiology research and practice. 13 [DOI] 10.1016/j.ahjo.2021.100080. [PMID] 36262746.
2022
Comparative Safety and Effectiveness of Aldosterone Antagonists Versus Beta-Blockers as Fourth Agents in Patients With Apparent Resistant Hypertension
Hypertension. 79(10):2305-2315 [DOI] 10.1161/hypertensionaha.122.19280.
2022
Concomitant coronary microvascular dysfunction and spontaneous coronary artery dissection resulting in ST-segment elevation myocardial infarction
Journal of Cardiology Cases. 25(2):76-78 [DOI] 10.1016/j.jccase.2021.06.014. [PMID] 35079302.
2022
Coronary Microvascular Dysfunction in Patients with Non-Obstructive Coronary Arteries: Current Gaps and Future Directions
Drugs. 82(3):241-250 [DOI] 10.1007/s40265-021-01667-y.
2022
Depression Symptom Patterns as Predictors of Metabolic Syndrome and Cardiac Events in Symptomatic Women with Suspected Myocardial Ischemia: The Women’s Ischemia Syndrome Evaluation (WISE and WISE-CVD) Projects.
Heart and mind (Mumbai, India). 6(4):254-261 [PMID] 36994354.
2022
Digital health intervention in patients with recent hospitalization for acute heart failure: A systematic review and meta-analysis of randomized trials.
International journal of cardiology. 359:46-53 [DOI] 10.1016/j.ijcard.2022.04.039. [PMID] 35436558.
2022
Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis.
Stem cells translational medicine. 11(7):688-703 [DOI] 10.1093/stcltm/szac032. [PMID] 35640138.
2022
Evaluation of a Beta-Blocker-Edema-Loop Diuretic Prescribing Cascade: A Prescription Sequence Symmetry Analysis.
American journal of hypertension. 35(7):601-609 [DOI] 10.1093/ajh/hpac013. [PMID] 35106529.
2022
Evaluation of the key prescription sequence symmetry analysis assumption using the calcium channel blocker: Loop diuretic prescribing cascade.
Pharmacoepidemiology and drug safety. 31(1):72-81 [DOI] 10.1002/pds.5362. [PMID] 34553438.
2022
First and recurrent events in the ISCHEMIA trial: two sides of the same coin
European Heart Journal. 43(2):150-152 [DOI] 10.1093/eurheartj/ehab603.
2022
Gut Microbiome and Neuroinflammation in Hypertension
Circulation Research. 130(3):401-417 [DOI] 10.1161/circresaha.121.319816.
2022
Identification of a Gut Commensal That Compromises the Blood Pressure-Lowering Effect of Ester Angiotensin-Converting Enzyme Inhibitors
Hypertension. 79(8):1591-1601 [DOI] 10.1161/hypertensionaha.121.18711.
2022
Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.
International journal of cardiology. 348:1-8 [DOI] 10.1016/j.ijcard.2021.12.013. [PMID] 34902504.
2022
Ischemic Heart Disease in Young Women: JACC Review Topic of the Week.
Journal of the American College of Cardiology. 80(10):1014-1022 [DOI] 10.1016/j.jacc.2022.01.057. [PMID] 36049799.
2022
Medicare Bundled Payment Policy on Anemia Care, Major Adverse Cardiovascular Events, and Mortality among Adults Undergoing Hemodialysis.
Clinical journal of the American Society of Nephrology : CJASN. 17(6):851-860 [DOI] 10.2215/CJN.14361121. [PMID] 35589388.
2022
Microvascular Dysfunction as a Systemic Disease: A Review of the Evidence
The American journal of medicine. 135(9):1059-1068 [DOI] 10.1016/j.amjmed.2022.04.006. [PMID] 35472396.
2022
Non-obstructive Plaque and Treatment of INOCA: More to Be Learned
Current Atherosclerosis Reports. 24(9):681-687 [DOI] 10.1007/s11883-022-01044-4. [PMID] 35781776.
2022
Our academic heritage from CR Conti—A lifetime committed to education and excellence
Clinical Cardiology. 45(11):1085-1088 [DOI] 10.1002/clc.23912. [PMID] 36165103.
2022
Prognostic association of plasma NT-proBNP levels in patients with microvascular angina -A report from the international cohort study by COVADIS.
International journal of cardiology. Heart & vasculature. 43 [DOI] 10.1016/j.ijcha.2022.101139. [PMID] 36338319.
2022
Recommendations for nomenclature and definition of cell products intended for human cardiovascular use.
Cardiovascular research. 118(11):2428-2436 [DOI] 10.1093/cvr/cvab270. [PMID] 34387303.
2022
Relationship of Psychological Characteristics to Daily Life Ischemia: An Analysis From the National Heart, Lung, and Blood Institute Psychophysiological Investigations in Myocardial Ischemia.
Psychosomatic medicine. 84(3):359-367 [DOI] 10.1097/PSY.0000000000001044. [PMID] 35067655.
2022
RNA Virus Gene Signatures Detected in Patients With Cardiomyopathy After Chemotherapy; A Pilot Study.
Frontiers in cardiovascular medicine. 9 [DOI] 10.3389/fcvm.2022.821162. [PMID] 35360008.
2022
Sex-dimorphic gene effects on survival outcomes in people with coronary artery disease.
American heart journal plus : cardiology research and practice. 17 [DOI] 10.1016/j.ahjo.2022.100152. [PMID] 35959094.
2022
Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women’s Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial)
The American Journal of Cardiology. 162:1-5 [DOI] 10.1016/j.amjcard.2021.09.015. [PMID] 34728061.
2022
The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports.
Journal of hypertension. 40(5):847-852 [DOI] 10.1097/HJH.0000000000003107. [PMID] 35221323.
2022
Trans-myocardial omega-3 fatty acid gradient in coronary microvascular dysfunction.
American heart journal plus : cardiology research and practice. 22 [DOI] 10.1016/j.ahjo.2022.100213. [PMID] 37377675.
2022
Ultra-high sensitivity cardiac troponin-I concentration and left ventricular structure and function in women with ischemia and no obstructive coronary artery disease.
American heart journal plus : cardiology research and practice. 13 [DOI] 10.1016/j.ahjo.2022.100115. [PMID] 35784010.
2022
What Is the Role of Assessing Ischemia to Optimize Therapy and Outcomes for Patients with Stable Angina and Non-obstructed Coronary Arteries?
Cardiovascular drugs and therapy. 36(5):1027-1038 [DOI] 10.1007/s10557-021-07179-x. [PMID] 33978865.
2021
A multiplexed ion-exchange membrane-based miRNA (MIX·miR) detection platform for rapid diagnosis of myocardial infarction.
Lab on a chip. 21(20):3876-3887 [DOI] 10.1039/d1lc00685a. [PMID] 34546237.
2021
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.
European journal of heart failure. 23(4):661-674 [DOI] 10.1002/ejhf.2178. [PMID] 33811444.
2021
A Six-Day, Lifestyle-Based Immersion Program Mitigates Cardiovascular Risk Factors and Induces Shifts in Gut Microbiota, Specifically Lachnospiraceae, Ruminococcaceae, Faecalibacterium prausnitzii: A Pilot Study
Nutrients. 13(10) [DOI] 10.3390/nu13103459. [PMID] 34684459.
2021
Acute Pulmonary Embolism During Pregnancy and Puerperium: National Trends and In-Hospital Outcomes.
Mayo Clinic proceedings. 96(8):2102-2113 [DOI] 10.1016/j.mayocp.2021.01.015. [PMID] 34144802.
2021
Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies.
Clinical pharmacology and therapeutics. 110(3):723-732 [DOI] 10.1002/cpt.2355. [PMID] 34231218.
2021
Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease.
International journal of cardiology. 333:35-39 [DOI] 10.1016/j.ijcard.2021.02.064. [PMID] 33662486.
2021
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
The Lancet. Oncology. 22(4):558-570 [DOI] 10.1016/S1470-2045(21)00033-4. [PMID] 33794209.
2021
Aspirin in Primary Prevention: What Changed? A Critical Appraisal of Current Evidence.
The American journal of cardiology. 141:38-48 [DOI] 10.1016/j.amjcard.2020.11.014. [PMID] 33221264.
2021
Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial.
JAMA network open. 4(4) [DOI] 10.1001/jamanetworkopen.2021.8418. [PMID] 33914047.
2021
Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker
Clinical Cardiology. 44(11):1586-1593 [DOI] 10.1002/clc.23726. [PMID] 34528718.
2021
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
Lancet (London, England). 398(10313):1803-1810 [DOI] 10.1016/S0140-6736(21)01920-6. [PMID] 34774144.
2021
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
PLoS medicine. 18(6) [DOI] 10.1371/journal.pmed.1003599. [PMID] 34061831.
2021
Butyrate Regulates COVID-19-Relevant Genes in Gut Epithelial Organoids From Normotensive Rats.
Hypertension (Dallas, Tex. : 1979). 77(2):e13-e16 [DOI] 10.1161/HYPERTENSIONAHA.120.16647. [PMID] 33439735.
2021
Cardiac Sympathetic Activity by 123I-Meta-Iodobenzylguanidine Imaging in Women With Coronary Microvascular Dysfunction: A Pilot Study.
JACC. Cardiovascular imaging. 14(9):1873-1875 [DOI] 10.1016/j.jcmg.2021.03.031. [PMID] 34147436.
2021
Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group
European Heart Journal. 42(44):4592-4600 [DOI] 10.1093/eurheartj/ehab282. [PMID] 34038937.
2021
Clinical Safety Profile of Transendocardial Catheter Injection Systems: A Plea for Uniform Reporting.
Cardiovascular revascularization medicine : including molecular interventions. 22:100-108 [DOI] 10.1016/j.carrev.2020.06.031. [PMID] 32651159.
2021
Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trial.
Clinical trials (London, England). 18(4):449-456 [DOI] 10.1177/1740774520988838. [PMID] 33541120.
2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.
The New England journal of medicine. 384(21):1981-1990 [DOI] 10.1056/NEJMoa2102137. [PMID] 33999548.
2021
Coronary endothelial dysfunction appears to be a manifestation of a systemic process: A report from the Women’s Ischemia Syndrome Evaluation – Coronary Vascular Dysfunction (WISE-CVD) study.
PloS one. 16(9) [DOI] 10.1371/journal.pone.0257184. [PMID] 34570768.
2021
Depression phenotype identified by using single nucleotide exact amplicon sequence variants of the human gut microbiome.
Molecular psychiatry. 26(8):4277-4287 [DOI] 10.1038/s41380-020-0652-5. [PMID] 31988436.
2021
Depressive hypertension: A proposed human endotype of brain/gut microbiome dysbiosis.
American heart journal. 239:27-37 [DOI] 10.1016/j.ahj.2021.05.002. [PMID] 33984318.
2021
Diagnostic Cardiovascular Imaging and Therapeutic Strategies in Pregnancy: JACC Focus Seminar 4/5.
Journal of the American College of Cardiology. 77(14):1813-1822 [DOI] 10.1016/j.jacc.2021.01.056. [PMID] 33832607.
2021
Distinct Gene Expression Profiles in Colonic Organoids from Normotensive and the Spontaneously Hypertensive Rats.
Cells. 10(6) [DOI] 10.3390/cells10061523. [PMID] 34204247.
2021
Does Patient-Physician Gender Concordance Influence Patient Perceptions or Outcomes?
Journal of the American College of Cardiology. 77(8):1135-1138 [DOI] 10.1016/j.jacc.2020.12.031. [PMID] 33632488.
2021
Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial.
JAMA. 326(17):1703-1712 [DOI] 10.1001/jama.2021.17272. [PMID] 34633405.
2021
Effectiveness of sacubitril/valsartan versus aldosterone antagonists in heart failure with reduced ejection fraction: A retrospective cohort study.
Pharmacotherapy. 41(9):710-721 [DOI] 10.1002/phar.2610. [PMID] 34170559.
2021
Efficacy of Ranolazine for Treatment of Coronary Microvascular Dysfunction-A Systematic Review and Meta-analysis of Randomized Trials.
CJC open. 3(1):101-108 [DOI] 10.1016/j.cjco.2020.09.005. [PMID] 33458636.
2021
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.
American heart journal. 241:38-49 [DOI] 10.1016/j.ahj.2021.06.013. [PMID] 34224684.
2021
Erratum to “Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era” AmJMed, 133(11); 1254-1261.
The American journal of medicine. 134(4) [DOI] 10.1016/j.amjmed.2021.01.001. [PMID] 33461734.
2021
Functional heart recovery in an adult mammal, the spiny mouse.
International journal of cardiology. 338:196-203 [DOI] 10.1016/j.ijcard.2021.06.015. [PMID] 34126132.
2021
Lactate Dehydrogenase B and Pyruvate Oxidation Pathway Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: Result of a Multi-Omics Integrative Analysis.
Frontiers in cardiovascular medicine. 8 [DOI] 10.3389/fcvm.2021.645122. [PMID] 33996940.
2021
Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women’s Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) Project.
International journal of cardiology. 327:25-30 [DOI] 10.1016/j.ijcard.2020.11.006. [PMID] 33202262.
2021
Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design.
American journal of nephrology. 52(1):36-44 [DOI] 10.1159/000513567. [PMID] 33640890.
2021
Management of Women With Acquired Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 3/5.
Journal of the American College of Cardiology. 77(14):1799-1812 [DOI] 10.1016/j.jacc.2021.01.057. [PMID] 33832606.
2021
Management of Women With Congenital or Inherited Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 2/5.
Journal of the American College of Cardiology. 77(14):1778-1798 [DOI] 10.1016/j.jacc.2021.02.026. [PMID] 33832605.
2021
Maternal Stroke
Circulation. 143(7):727-738 [DOI] 10.1161/circulationaha.120.051460.
2021
Maternal Stroke
Circulation. 143(7):727-738 [DOI] 10.1161/circulationaha.120.051460.
2021
Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center.
Cardio-oncology (London, England). 7(1) [DOI] 10.1186/s40959-021-00097-9. [PMID] 33736707.
2021
Peak Systolic Blood Pressure During the Exercise Test: Reference Values by Sex and Age and Association With Mortality
Hypertension. 77(6):1906-1914 [DOI] 10.1161/hypertensionaha.120.16570.
2021
Perfusion, cryopreservation, and nanowarming of whole hearts using colloidally stable magnetic cryopreservation agent solutions.
Science advances. 7(2) [DOI] 10.1126/sciadv.abe3005. [PMID] 33523997.
2021
Peripheral Blood Biomarkers Associated With Improved Functional Outcome in Patients With Chronic Left Ventricular Dysfunction: A Biorepository Evaluation of the FOCUS-CCTRN Trial.
Frontiers in cardiovascular medicine. 8 [DOI] 10.3389/fcvm.2021.698088. [PMID] 34540912.
2021
Phytoestrogen blood levels and adverse outcomes in women with suspected ischemic heart disease
European Journal of Clinical Nutrition. 75(5):829-835 [DOI] 10.1038/s41430-020-00800-6.
2021
Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.
International journal of cardiology. 326:131-138 [DOI] 10.1016/j.ijcard.2020.10.043. [PMID] 33091520.
2021
Potential of Minocycline for Treatment of Resistant Hypertension.
The American journal of cardiology. 156:147-149 [DOI] 10.1016/j.amjcard.2021.07.004. [PMID] 34348841.
2021
Preparticipation Cardiac Evaluation Findings in a Cohort of Collegiate Female Athletes
The American Journal of Cardiology. 140:134-139 [DOI] 10.1016/j.amjcard.2020.10.055. [PMID] 33144161.
2021
Prior Oral Contraceptive Use and Longer Term Mortality Outcomes in Women with Suspected Ischemic Heart Disease.
Journal of women's health (2002). 30(3):377-384 [DOI] 10.1089/jwh.2020.8743. [PMID] 33481672.
2021
Rationale and design of the Women’s Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial.
American heart journal. 237:90-103 [DOI] 10.1016/j.ahj.2021.03.011. [PMID] 33745898.
2021
Relationship between coronary function testing and migraine: results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction project.
Vessel plus. 5 [DOI] 10.20517/2574-1209.2021.55. [PMID] 35530745.
2021
Reply to “Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link”.
International journal of cardiology. 328 [DOI] 10.1016/j.ijcard.2020.11.058. [PMID] 33248187.
2021
Reproductive lifespan and incident stroke risk among post-menopausal women: Is it time for sex-specific risk prediction tools?
International journal of cardiology. 328:218-219 [DOI] 10.1016/j.ijcard.2020.12.032. [PMID] 33359280.
2021
Sex and gender differences in COVID-19: More to be learned!
American heart journal plus : cardiology research and practice. 3 [DOI] 10.1016/j.ahjo.2021.100011. [PMID] 34169297.
2021
Sex Differences, Aspirin, and Primary Prevention
The American Journal of Medicine. 134(1):9-10 [DOI] 10.1016/j.amjmed.2020.08.014.
2021
Somatic Versus Cognitive Depressive Symptoms as Predictors of Coronary Artery Disease among Women with Suspected Ischemia: The Women’s Ischemia Syndrome Evaluation.
Heart and mind (Mumbai, India). 5(4):112-118 [DOI] 10.4103/hm.hm_34_21. [PMID] 34966880.
2021
Syndrome of Nonobstructive Coronary Artery Diseases: A Comprehensive Overview of Open Artery Ischemia
The American Journal of Medicine. 134(11):1321-1329 [DOI] 10.1016/j.amjmed.2021.06.038. [PMID] 34343507.
2021
The Clinical Spectrum of Myocardial Infarction and Ischemia With Nonobstructive Coronary Arteries in Women.
JACC. Cardiovascular imaging. 14(5):1053-1062 [DOI] 10.1016/j.jcmg.2020.06.044. [PMID] 33011128.
2021
The role of a comprehensive two-step diagnostic evaluation to unravel the pathophysiology of MINOCA: A review.
International journal of cardiology. 336:1-7 [DOI] 10.1016/j.ijcard.2021.05.045. [PMID] 34087335.
2021
Women and atrial fibrillation.
Journal of cardiovascular electrophysiology. 32(10):2793-2807 [DOI] 10.1111/jce.14838. [PMID] 33332669.
2020
A Cardio-Obstetric Approach to Management of the Complex Pregnant Cardiac Patient.
JACC. Case reports. 2(1):86-90 [DOI] 10.1016/j.jaccas.2019.12.008. [PMID] 34316971.
2020
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
Hypertension (Dallas, Tex. : 1979). 76(3):651-661 [DOI] 10.1161/HYPERTENSIONAHA.120.15595. [PMID] 32783758.
2020
Acute Stroke During Pregnancy and Puerperium.
Journal of the American College of Cardiology. 75(2):180-190 [DOI] 10.1016/j.jacc.2019.10.056. [PMID] 31948647.
2020
Adverse Pregnancy Outcomes Are Associated with Reduced Coronary Flow Reserve in Women With Signs and Symptoms of Ischemia Without Obstructive Coronary Artery Disease: A Report from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.
Journal of women's health (2002). 29(4):487-492 [DOI] 10.1089/jwh.2019.7925. [PMID] 31859580.
2020
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial.
JACC. CardioOncology. 2(4):581-595 [DOI] 10.1016/j.jaccao.2020.09.001. [PMID] 33403362.
2020
Altered Gut Microbiome Profile in Patients With Pulmonary Arterial Hypertension.
Hypertension (Dallas, Tex. : 1979). 75(4):1063-1071 [DOI] 10.1161/HYPERTENSIONAHA.119.14294. [PMID] 32088998.
2020
Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women’s Ischemia Syndrome Evaluation) Study.
Journal of the American Heart Association. 9(4) [DOI] 10.1161/JAHA.119.013168. [PMID] 32063125.
2020
Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When.
JACC. Cardiovascular interventions. 13(16):1847-1864 [DOI] 10.1016/j.jcin.2020.05.052. [PMID] 32819476.
2020
Association of Factor V Leiden With Subsequent Atherothrombotic Events
Circulation. 142(6):546-555 [DOI] 10.1161/circulationaha.119.045526.
2020
Association of Factor V Leiden With Subsequent Atherothrombotic Events
Circulation. 142(6):546-555 [DOI] 10.1161/circulationaha.119.045526.
2020
Attended vs unattended systolic blood pressure measurement: A randomized comparison in patients with cardiovascular disease.
Journal of clinical hypertension (Greenwich, Conn.). 22(11):1987-1992 [DOI] 10.1111/jch.14037. [PMID] 32951360.
2020
Cardiac stem cell therapy among Clinics of Uncertain Regulatory Status (COURS): under-regulated, under-observed, incompletely understood.
Journal of translational medicine. 18(1) [DOI] 10.1186/s12967-020-02425-6. [PMID] 32678051.
2020
Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era
The American Journal of Medicine. 133(11):1254-1261 [DOI] 10.1016/j.amjmed.2020.06.005. [PMID] 32653420.
2020
Cell Therapy Strategies With No Safety Concerns and Demonstrated Benefits Warrant Study.
Circulation journal : official journal of the Japanese Circulation Society. 84(11):2120-2121 [DOI] 10.1253/circj.CJ-19-1175. [PMID] 33041288.
2020
Commentary – The ISCHEMIA trial.
International journal of cardiology. 304:1-4 [DOI] 10.1016/j.ijcard.2020.02.011. [PMID] 32059992.
2020
Coronary Vascular Function and Cardiomyocyte Injury
Arteriosclerosis, Thrombosis, and Vascular Biology. 40(12):3015-3021 [DOI] 10.1161/atvbaha.120.314260.
2020
Coronary Vascular Function and Cardiomyocyte Injury
Arteriosclerosis, Thrombosis, and Vascular Biology. 40(12):3015-3021 [DOI] 10.1161/atvbaha.120.314260.
2020
Design, methodology and baseline characteristics of the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).
American heart journal. 220:224-236 [DOI] 10.1016/j.ahj.2019.11.017. [PMID] 31884245.
2020
Even “WISE-R?”-an Update on the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation.
Current atherosclerosis reports. 22(8) [DOI] 10.1007/s11883-020-00852-w. [PMID] 32556630.
2020
Heart failure with preserved ejection fraction: Similarities and differences between women and men.
International journal of cardiology. 304:101-108 [DOI] 10.1016/j.ijcard.2020.01.003. [PMID] 31959407.
2020
Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy
Journal of Clinical Medicine. 9(1) [DOI] 10.3390/jcm9010241. [PMID] 31963368.
2020
International prospective cohort study of microvascular angina – Rationale and design.
International journal of cardiology. Heart & vasculature. 31 [DOI] 10.1016/j.ijcha.2020.100630. [PMID] 32984497.
2020
Invasive Functional Assessment in Patients With Angina and Coronary Microvascular Dysfunction: A Plea for More.
Journal of the American College of Cardiology. 75(20):2550-2552 [DOI] 10.1016/j.jacc.2020.03.052. [PMID] 32439004.
2020
Left ventricular mass and myocardial scarring in women with hypertensive disorders of pregnancy.
Open heart. 7(2) [DOI] 10.1136/openhrt-2020-001273. [PMID] 32763966.
2020
Maternal Treatment With Captopril Persistently Alters Gut-Brain Communication and Attenuates Hypertension of Male Offspring.
Hypertension (Dallas, Tex. : 1979). 75(5):1315-1324 [DOI] 10.1161/HYPERTENSIONAHA.120.14736. [PMID] 32200676.
2020
Myocardial Infarction and Persistent Angina With No Obstructive Coronary Artery Disease.
JACC. Case reports. 2(1):9-14 [DOI] 10.1016/j.jaccas.2019.11.049. [PMID] 34316956.
2020
Myocardial ischemia: From disease to syndrome.
International journal of cardiology. 314:32-35 [DOI] 10.1016/j.ijcard.2020.04.074. [PMID] 32348810.
2020
N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
PloS one. 15(12) [DOI] 10.1371/journal.pone.0243213. [PMID] 33270715.
2020
Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women’s Ischemic Syndrome Evaluation study (WISE).
International journal of cardiology. Heart & vasculature. 27 [DOI] 10.1016/j.ijcha.2020.100502. [PMID] 32226820.
2020
Optimal systolic blood pressure and reduced long-term mortality in older hypertensive women with prior coronary events – An analysis from INVEST☆.
International Journal of Cardiology. Hypertension. 7 [DOI] 10.1016/j.ijchy.2020.100052. [PMID] 33817619.
2020
Oxidative Stress Is Associated With Diastolic Dysfunction in Women With Ischemia With No Obstructive Coronary Artery Disease.
Journal of the American Heart Association. 9(10) [DOI] 10.1161/JAHA.119.015602. [PMID] 32375556.
2020
Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women’s Ischemia Syndrome Evaluation).
Journal of the American Heart Association. 9(7) [DOI] 10.1161/JAHA.119.013234. [PMID] 32268814.
2020
Psychological stress, cardiac symptoms, and cardiovascular risk in women with suspected ischaemia but no obstructive coronary disease.
Stress and health : journal of the International Society for the Investigation of Stress. 36(3):264-273 [DOI] 10.1002/smi.2928. [PMID] 31957961.
2020
Redefining Resistant Hypertension: A Comparison of Cardiovascular Risk Associated With the 2018 Versus 2008 American Heart Association Definitions for Resistant Hypertension.
Circulation. Cardiovascular quality and outcomes. 13(2) [DOI] 10.1161/CIRCOUTCOMES.119.005979. [PMID] 32008359.
2020
Reply: Factors Associated With Acute Stroke During Pregnancy and Puerperium.
Journal of the American College of Cardiology. 75(17):2280-2281 [DOI] 10.1016/j.jacc.2020.03.014. [PMID] 32354396.
2020
Resting coronary velocity and myocardial performance in women with impaired coronary flow reserve: Results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
International journal of cardiology. 309:19-22 [DOI] 10.1016/j.ijcard.2020.01.053. [PMID] 32037132.
2020
Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).
Journal of women's health (2002). 29(2):158-166 [DOI] 10.1089/jwh.2018.7235. [PMID] 31403360.
2020
Statin Use for Atherosclerotic Cardiovascular Disease Prevention Among Sexual Minority Adults
Journal of the American Heart Association. 9(24) [DOI] 10.1161/jaha.120.018233.
2020
Statin Use for Atherosclerotic Cardiovascular Disease Prevention Among Sexual Minority Adults
Journal of the American Heart Association. 9(24) [DOI] 10.1161/jaha.120.018233.
2020
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review.
Journal of the American College of Cardiology. 75(20):2602-2618 [DOI] 10.1016/j.jacc.2020.03.060. [PMID] 32439010.
2020
Systolic blood pressure, heart rate, and outcomes in patients with coronary disease and heart failure.
ESC heart failure. 7(1):123-129 [DOI] 10.1002/ehf2.12534. [PMID] 31840441.
2020
Temporal Trends in Angina, Myocardial Perfusion, and Left Ventricular Remodeling in Women With No Obstructive Coronary Artery Disease Over 1-Year Follow-Up: Results From WISE-CVD.
Journal of the American Heart Association. 9(13) [DOI] 10.1161/JAHA.119.016305. [PMID] 32578481.
2020
Thiazide Exposure and Cardiovascular Risk in Type 2 Diabetes Mellitus: A Point of Clarification.
Hypertension (Dallas, Tex. : 1979). 75(3):e2-e5 [DOI] 10.1161/HYPERTENSIONAHA.119.14447. [PMID] 32008437.
2020
Transcriptomic signature of gut microbiome-contacting cells in colon of spontaneously hypertensive rats.
Physiological genomics. 52(3):121-132 [DOI] 10.1152/physiolgenomics.00087.2019. [PMID] 31869283.
2020
Treatment of coronary microvascular dysfunction
Cardiovascular Research. 116(4):856-870 [DOI] 10.1093/cvr/cvaa006. [PMID] 32087007.
2020
What is the Real Message of the ISCHEMIA Trial from a Clinician’s Perspective?
European cardiology. 15 [DOI] 10.15420/ecr.2020.27. [PMID] 32983263.
2020
Why are women better protected from COVID-19: Clues for men? Sex and COVID-19.
International journal of cardiology. 315:105-106 [DOI] 10.1016/j.ijcard.2020.05.026. [PMID] 32418736.
2020
Would Repurposing Minocycline Alleviate Neurologic Manifestations of COVID-19?
Frontiers in neuroscience. 14 [DOI] 10.3389/fnins.2020.577780. [PMID] 33117121.
2019
Adenosine vs Regadenoson Pharmacologic Stress Differs in Women with Suspected Coronary Microvascular Dysfunction: A Report from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) Study.
Cardiovascular disorder and medicine. 2019 [DOI] 10.31487/j.cdm.2019.01.01. [PMID] 36913201.
2019
Advances in small-molecule therapy for managing angina pectoris in the elderly.
Expert opinion on pharmacotherapy. 20(12):1471-1481 [DOI] 10.1080/14656566.2019.1615881. [PMID] 31107109.
2019
Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation.
Journal of the American Heart Association. 8(12) [DOI] 10.1161/JAHA.119.012406. [PMID] 31165670.
2019
Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events.
Circulation. Genomic and precision medicine. 12(4) [DOI] 10.1161/CIRCGEN.119.002471. [PMID] 30897348.
2019
Complementary Embryonic and Adult Cell Populations Enhance Myocardial Repair in Rat Myocardial Injury Model.
Stem cells international. 2019 [DOI] 10.1155/2019/3945850. [PMID] 31781239.
2019
First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients.
JACC. Basic to translational science. 4(6):659-669 [DOI] 10.1016/j.jacbts.2019.07.012. [PMID] 31709316.
2019
Gender in cardiovascular medicine: chest pain and coronary artery disease
European Heart Journal. 40(47):3819-3826 [DOI] 10.1093/eurheartj/ehz784. [PMID] 31713592.
2019
Genome-wide association analysis of common genetic variants of resistant hypertension
The Pharmacogenomics Journal. 19(3):295-304 [DOI] 10.1038/s41397-018-0049-x. [PMID] 30237584.
2019
Genome-Wide Meta-Analysis of Blood Pressure Response to β1-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies).
Journal of the American Heart Association. 8(16) [DOI] 10.1161/JAHA.119.013115. [PMID] 31423876.
2019
Heart Failure With Preserved Ejection Fraction: Is Ischemia Due to Coronary Microvascular Dysfunction a Mechanistic Factor?
The American Journal of Medicine. 132(6):692-697 [DOI] 10.1016/j.amjmed.2018.12.038. [PMID] 30684452.
2019
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women.
Journal of the American College of Cardiology. 73(6):684-693 [DOI] 10.1016/j.jacc.2018.11.040. [PMID] 30765035.
2019
Impaired Autonomic Nervous System-Microbiome Circuit in Hypertension.
Circulation research. 125(1):104-116 [DOI] 10.1161/CIRCRESAHA.119.313965. [PMID] 31219753.
2019
Incidence, prevalence, and predictors of treatment-resistant hypertension with intensive blood pressure lowering.
Journal of clinical hypertension (Greenwich, Conn.). 21(6):825-834 [DOI] 10.1111/jch.13550. [PMID] 31066177.
2019
Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC).
BMJ open. 9(5) [DOI] 10.1136/bmjopen-2018-028698. [PMID] 31123005.
2019
Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary study.
International journal of cardiology. 276:8-13 [DOI] 10.1016/j.ijcard.2018.09.081. [PMID] 30293664.
2019
Left ventricular concentric remodelling and functional impairment in women with ischaemia with no obstructive coronary artery disease and intermediate coronary flow reserve: a report from the WISE-CVD study.
European heart journal. Cardiovascular Imaging. 20(8):875-882 [DOI] 10.1093/ehjci/jez044. [PMID] 30904924.
2019
Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.
JAMA network open. 2(12) [DOI] 10.1001/jamanetworkopen.2019.18425. [PMID] 31880802.
2019
Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization.
European heart journal. 40(29):2455-2462 [DOI] 10.1093/eurheartj/ehy857. [PMID] 30608528.
2019
Medical Therapy for Heart Failure Caused by Ischemic Heart Disease.
Circulation research. 124(11):1520-1535 [DOI] 10.1161/CIRCRESAHA.118.313568. [PMID] 31120824.
2019
Microglial Cells Impact Gut Microbiota and Gut Pathology in Angiotensin II-Induced Hypertension.
Circulation research. 124(5):727-736 [DOI] 10.1161/CIRCRESAHA.118.313882. [PMID] 30612527.
2019
Migraine Headache: An Under-Appreciated Risk Factor for Cardiovascular Disease in Women.
Journal of the American Heart Association. 8(22) [DOI] 10.1161/JAHA.119.014546. [PMID] 31707945.
2019
Novel Self-Report Tool for Cardiovascular Risk Assessment.
Journal of the American Heart Association. 8(24) [DOI] 10.1161/JAHA.119.014123. [PMID] 31818214.
2019
Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).
Journal of interventional cardiology. 2019 [DOI] 10.1155/2019/7169275. [PMID] 31772544.
2019
Sex and Race/Ethnicity Differences in Atrial Fibrillation.
Journal of the American College of Cardiology. 74(22):2812-2815 [DOI] 10.1016/j.jacc.2019.09.045. [PMID] 31779796.
2019
Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women?
Journal of the American Heart Association. 8(19) [DOI] 10.1161/JAHA.119.013154. [PMID] 31549581.
2019
Subsequent Event Risk in Individuals With Established Coronary Heart Disease.
Circulation. Genomic and precision medicine. 12(4) [DOI] 10.1161/CIRCGEN.119.002470. [PMID] 30896328.
2019
Sustained Captopril-Induced Reduction in Blood Pressure Is Associated With Alterations in Gut-Brain Axis in the Spontaneously Hypertensive Rat.
Journal of the American Heart Association. 8(4) [DOI] 10.1161/JAHA.118.010721. [PMID] 30755073.
2019
β2 -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies.
Journal of clinical pharmacology. 59(11):1462-1470 [DOI] 10.1002/jcph.1443. [PMID] 31090079.
2018
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy.
Scientific reports. 8(1) [DOI] 10.1038/s41598-018-22121-2. [PMID] 29511207.
2018
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data.
PLoS medicine. 15(3) [DOI] 10.1371/journal.pmed.1002538. [PMID] 29558462.
2018
Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation.
Cardiovascular diagnosis and therapy. 8(4):405-413 [DOI] 10.21037/cdt.2018.04.03. [PMID] 30214855.
2018
Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes.
The pharmacogenomics journal. 18(1):106-112 [DOI] 10.1038/tpj.2016.67. [PMID] 27670767.
2018
Gut microbiota and serum metabolite differences in African Americans and White Americans with high blood pressure.
International journal of cardiology. 271:336-339 [DOI] 10.1016/j.ijcard.2018.04.074. [PMID] 30049487.
2018
High sensitivity cardiac troponin T and I and risk stratification of patients with stable CHD: Is it time to incorporate this in routine clinical practice?
International journal of cardiology. 250:266-267 [DOI] 10.1016/j.ijcard.2017.10.007. [PMID] 29169758.
2018
Hypertension Across a Woman’s Life Cycle.
Journal of the American College of Cardiology. 71(16):1797-1813 [DOI] 10.1016/j.jacc.2018.02.033. [PMID] 29673470.
2018
Hypertension in Florida: Data From the OneFlorida Clinical Data Research Network.
Preventing chronic disease. 15 [DOI] 10.5888/pcd15.170332. [PMID] 29494332.
2018
Hypertension in pregnancy: Taking cues from pathophysiology for clinical practice
Clinical Cardiology. 41(2):220-227 [DOI] 10.1002/clc.22892. [PMID] 29485737.
2018
Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure.
Clinical science (London, England : 1979). 132(6):701-718 [DOI] 10.1042/CS20180087. [PMID] 29507058.
2018
Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression.
Gut. 67(8):1555-1557 [DOI] 10.1136/gutjnl-2017-314759. [PMID] 28814485.
2018
Intensive blood pressure lowering reduces adverse cardiovascular outcomes among patients with high-normal glucose: An analysis from the Systolic Blood Pressure Intervention Trial database.
Journal of clinical hypertension (Greenwich, Conn.). 20(4):620-624 [DOI] 10.1111/jch.13247. [PMID] 29532983.
2018
Intracoronary Bolus Injection Versus Intravenous Infusion of Adenosine for Assessment of Coronary Flow Velocity Reserve in Women With Signs and Symptoms of Myocardial Ischemia and No Obstructive Coronary Artery Disease.
JACC. Cardiovascular interventions. 11(20):2125-2127 [DOI] 10.1016/j.jcin.2018.07.052. [PMID] 30336817.
2018
Ischemia and No Obstructive Coronary Artery Disease ( INOCA ): What Is the Risk?
Journal of the American Heart Association. 7(17) [DOI] 10.1161/JAHA.118.008868. [PMID] 30371178.
2018
Long-term mortality and estimated functional capacity among women with symptoms of ischemic heart disease: From the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation.
American heart journal. 206:123-126 [DOI] 10.1016/j.ahj.2018.08.010. [PMID] 30237012.
2018
Maladaptive left ventricular remodeling in women: An analysis from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction study.
International journal of cardiology. 268:230-235 [DOI] 10.1016/j.ijcard.2018.03.139. [PMID] 30041793.
2018
Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort.
Journal of hypertension. 36(2):419-427 [DOI] 10.1097/HJH.0000000000001559. [PMID] 28938338.
2018
Myocardial Scar Is Prevalent and Associated With Subclinical Myocardial Dysfunction in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease: From the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.
Circulation. 137(8):874-876 [DOI] 10.1161/CIRCULATIONAHA.117.031999. [PMID] 29459474.
2018
Not All Stem Cells Are Created Equal.
Circulation research. 123(8):944-946 [DOI] 10.1161/CIRCRESAHA.118.313425. [PMID] 30355037.
2018
Optimal medical treatment of hypertension in patients with coronary artery disease.
Expert review of cardiovascular therapy. 16(11):815-823 [DOI] 10.1080/14779072.2018.1534069. [PMID] 30295548.
2018
Optimal Systolic Blood Pressure Target in Resistant and Non-Resistant Hypertension: A Pooled Analysis of Patient-Level Data from SPRINT and ACCORD.
The American journal of medicine. 131(12):1463-1472.e7 [DOI] 10.1016/j.amjmed.2018.08.005. [PMID] 30142317.
2018
Prevalence, Causes, and Predictors of 30-Day Readmissions Following Hospitalization With Acute Myocardial Infarction Complicated By Cardiogenic Shock: Findings From the 2013-2014 National Readmissions Database.
Journal of the American Heart Association. 7(6) [DOI] 10.1161/JAHA.117.008235. [PMID] 29572325.
2018
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure).
Circulation research. 122(12):1703-1715 [DOI] 10.1161/CIRCRESAHA.118.312978. [PMID] 29703749.
2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial.
American heart journal. 201:54-62 [DOI] 10.1016/j.ahj.2018.02.009. [PMID] 29910056.
2018
Regenerative Medicine in the State of Florida: Letter Outlining the Florida Organization for Regenerative Medicine.
Stem cells translational medicine. 7(7):511-512 [DOI] 10.1002/sctm.18-0066. [PMID] 30403444.
2018
The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study design.
American heart journal. 201:141-148 [DOI] 10.1016/j.ahj.2018.03.016. [PMID] 29803986.
2018
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Nature Reviews Nephrology. 14(7):442-456 [DOI] 10.1038/s41581-018-0018-2. [PMID] 29760448.
2018
The Reply.
The American journal of medicine. 131(2) [DOI] 10.1016/j.amjmed.2017.10.025. [PMID] 29362110.
2018
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
Circulation research. 122(3):479-488 [DOI] 10.1161/CIRCRESAHA.117.311466. [PMID] 29208679.
2018
Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk Factors.
Cardiovascular toxicology. 18(2):184-191 [DOI] 10.1007/s12012-017-9429-8. [PMID] 29022233.
2018
Why names matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease)
Clinical Cardiology. 41(2):185-193 [DOI] 10.1002/clc.22894. [PMID] 29498752.
2017
Acetylcholine versus cold pressor testing for evaluation of coronary endothelial function.
PloS one. 12(2) [DOI] 10.1371/journal.pone.0172538. [PMID] 28207868.
2017
Advancements in pharmacotherapy for angina.
Expert opinion on pharmacotherapy. 18(5):457-469 [DOI] 10.1080/14656566.2017.1303483. [PMID] 28264619.
2017
Aortic flow conditions predict ejection efficiency in the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE).
Cardiovascular diagnosis and therapy. 7(3):288-295 [DOI] 10.21037/cdt.2017.03.07. [PMID] 28567354.
2017
Blood pressure, heart rate, and double product: lessons learned from Japan.
Journal of hypertension. 35(9):1785-1786 [DOI] 10.1097/HJH.0000000000001403. [PMID] 28767488.
2017
Cardiac Cell Therapy Evolving From Complex to Straightforward: Enabling Adoption and Affordability.
Circulation research. 121(10):1116-1118 [DOI] 10.1161/CIRCRESAHA.117.311947. [PMID] 29074527.
2017
Cardiovascular safety of NSAIDs: Additional insights after PRECISION and point of view
Clinical Cardiology. 40(12):1352-1356 [DOI] 10.1002/clc.22814. [PMID] 29247518.
2017
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy.
Scientific reports. 7(1) [DOI] 10.1038/s41598-017-04801-7. [PMID] 28667255.
2017
Cold Pressor Stress Cardiac Magnetic Resonance Myocardial Flow Reserve Is Not Useful for Detection of Coronary Endothelial Dysfunction in Women with Signs and Symptoms of Ischemia and No Obstructive CAD.
PloS one. 12(1) [DOI] 10.1371/journal.pone.0169818. [PMID] 28081214.
2017
Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial
JMIR Research Protocols. 6(12) [DOI] 10.2196/resprot.8057. [PMID] 29263019.
2017
Effect of Low-Furanocoumarin Hybrid Grapefruit Juice Consumption on Midazolam Pharmacokinetics.
Journal of clinical pharmacology. 57(3):305-311 [DOI] 10.1002/jcph.807. [PMID] 27503364.
2017
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).
Circulation. 135(15):1417-1428 [DOI] 10.1161/CIRCULATIONAHA.116.025707. [PMID] 28209728.
2017
Fertility Therapy and Long-Term Cardiovascular Risk: Raising More Questions Than Answers?
Journal of the American College of Cardiology. 70(10):1214-1215 [DOI] 10.1016/j.jacc.2017.07.731. [PMID] 28859783.
2017
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms.
Nature genetics. 49(7):1113-1119 [DOI] 10.1038/ng.3874. [PMID] 28530674.
2017
Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
Journal of the American Heart Association. 6(11) [DOI] 10.1161/JAHA.117.006522. [PMID] 29097388.
2017
Gut Microbiota: Potential for a Unifying Hypothesis for Prevention and Treatment of Hypertension.
Circulation research. 120(11):1724-1726 [DOI] 10.1161/CIRCRESAHA.117.310734. [PMID] 28546357.
2017
Hypertension-Linked Pathophysiological Alterations in the Gut.
Circulation research. 120(2):312-323 [DOI] 10.1161/CIRCRESAHA.116.309006. [PMID] 27799253.
2017
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials.
Basic research in cardiology. 112(1) [PMID] 27882430.
2017
Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
PloS one. 12(5) [DOI] 10.1371/journal.pone.0177684. [PMID] 28542263.
2017
Intestinal Permeability Biomarker Zonulin is Elevated in Healthy Aging.
Journal of the American Medical Directors Association. 18(9):810.e1-810.e4 [DOI] 10.1016/j.jamda.2017.05.018. [PMID] 28676292.
2017
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.
Circulation. 135(11):1075-1092 [DOI] 10.1161/CIRCULATIONAHA.116.024534. [PMID] 28289007.
2017
Menopausal symptoms and cardiovascular disease mortality in the Women’s Ischemia Syndrome Evaluation (WISE).
Menopause (New York, N.Y.). 24(2):126-132 [DOI] 10.1097/GME.0000000000000731. [PMID] 27676638.
2017
Migraine Headache and Long-Term Cardiovascular Outcomes: An Extended Follow-Up of the Women’s Ischemia Syndrome Evaluation.
The American journal of medicine. 130(6):738-743 [DOI] 10.1016/j.amjmed.2016.12.028. [PMID] 28109970.
2017
Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine.
Clinical cardiology. 40(5):300-306 [DOI] 10.1002/clc.22660. [PMID] 28004395.
2017
Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function.
Circulation research. 120(12):1947-1957 [DOI] 10.1161/CIRCRESAHA.116.309947. [PMID] 28490433.
2017
Quality and Equitable Health Care Gaps for Women: Attributions to Sex Differences in Cardiovascular Medicine.
Journal of the American College of Cardiology. 70(3):373-388 [DOI] 10.1016/j.jacc.2017.05.051. [PMID] 28705320.
2017
Report of the National Heart, Lung, and Blood Institute Working Group on the Role of Microbiota in Blood Pressure Regulation: Current Status and Future Directions.
Hypertension (Dallas, Tex. : 1979). [DOI] 10.1161/HYPERTENSIONAHA.117.09699. [PMID] 28760940.
2017
Resistant Hypertension: Mechanisms and Treatment.
Current hypertension reports. 19(7) [DOI] 10.1007/s11906-017-0754-x. [PMID] 28597403.
2017
Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women’s Ischemia Syndrome Evaluation Study.
Journal of the American Heart Association. 6(8) [DOI] 10.1161/JAHA.117.005501. [PMID] 28862961.
2017
Systolic blood pressure target: Have we identified the optimal target yet?
Journal of public health and emergency. 1 [DOI] 10.21037/jphe.2017.06.04. [PMID] 30148257.
2017
Ten-Year Mortality in the WISE Study (Women’s Ischemia Syndrome Evaluation).
Circulation. Cardiovascular quality and outcomes. 10(12) [DOI] 10.1161/CIRCOUTCOMES.116.003863. [PMID] 29217675.
2017
The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 89(2):169-177 [DOI] 10.1002/ccd.26601. [PMID] 27148802.
2017
The Gut, Its Microbiome, and Hypertension.
Current hypertension reports. 19(4) [DOI] 10.1007/s11906-017-0734-1. [PMID] 28444579.
2017
Typical angina is associated with greater coronary endothelial dysfunction but not abnormal vasodilatory reserve.
Clinical cardiology. 40(10):886-891 [DOI] 10.1002/clc.22740. [PMID] 28605043.
2016
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.
European heart journal. 37(19):1504-13 [DOI] 10.1093/eurheartj/ehv647. [PMID] 26614823.
2016
An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in rats.
International journal of cardiology. 220:149-54 [DOI] 10.1016/j.ijcard.2016.06.158. [PMID] 27379917.
2016
Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia.
Journal of molecular medicine (Berlin, Germany). 94(1):37-49 [PMID] 26498282.
2016
Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy.
Texas Heart Institute journal. 43(4):291-6 [DOI] 10.14503/THIJ-15-5341. [PMID] 27547135.
2016
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study.
Cell transplantation. 25(9):1701-1711 [PMID] 27151378.
2016
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
American heart journal. 179:142-50 [DOI] 10.1016/j.ahj.2016.06.018. [PMID] 27595689.
2016
Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics.
Circulation research. 118(8):1327-36 [DOI] 10.1161/CIRCRESAHA.116.307709. [PMID] 27081113.
2016
Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome.
Journal of women's health (2002). 25(9):875-81 [DOI] 10.1089/jwh.2015.5441. [PMID] 27267867.
2016
CES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril.
European journal of clinical pharmacology. 72(6):681-7 [DOI] 10.1007/s00228-016-2029-x. [PMID] 26915813.
2016
Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation – Coronary Vascular Dysfunction Study (WISE-CVD).
Atherosclerosis. 253:111-117 [DOI] 10.1016/j.atherosclerosis.2016.08.026. [PMID] 27596135.
2016
Correction: Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy.
PloS one. 11(6) [DOI] 10.1371/journal.pone.0157212. [PMID] 27258057.
2016
Experimental and early investigational drugs for angina pectoris.
Expert opinion on investigational drugs. 25(12):1413-1421 [PMID] 27791405.
2016
Genetic loci associated with nonobstructive coronary artery disease in Caucasian women.
Physiological genomics. 48(1):12-20 [DOI] 10.1152/physiolgenomics.00067.2015. [PMID] 26534935.
2016
Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women’s ischemia syndrome evaluation study.
International journal of cardiology. 223:936-939 [DOI] 10.1016/j.ijcard.2016.07.301. [PMID] 27589041.
2016
Hypertension-linked mechanical changes of rat gut.
Acta biomaterialia. 45:296-302 [DOI] 10.1016/j.actbio.2016.08.045. [PMID] 27567964.
2016
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial.
Cell transplantation. 25(9):1675-1687 [PMID] 26590374.
2016
Ischemic Predictors of Outcomes in Women With Signs and Symptoms of Ischemia and Nonobstructive Coronary Artery Disease.
JAMA cardiology. 1(4):491-2 [DOI] 10.1001/jamacardio.2016.0740. [PMID] 27438329.
2016
Long-Term Mortality in Hypertensive Patients With Coronary Artery Disease: Results From the US Cohort of the International Verapamil (SR)/Trandolapril Study.
Hypertension (Dallas, Tex. : 1979). 68(5):1110-1114 [PMID] 27620390.
2016
Mental Stress and Myocardial Ischemia: Young Women at Risk.
Journal of the American Heart Association. 5(9) [DOI] 10.1161/JAHA.116.004196. [PMID] 27559073.
2016
Mortality Risk Associated With Resistant Hypertension Among Women: Analysis from Three Prospective Cohorts Encompassing the Spectrum of Women’s Heart Disease.
Journal of women's health (2002). 25(10):996-1003 [PMID] 27224417.
2016
Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease.
JACC. Cardiovascular imaging. 9(4):421-35 [DOI] 10.1016/j.jcmg.2016.01.004. [PMID] 27056162.
2016
Predictors of short- and long-term mortality in hospitalized veterans with elevated troponin.
Journal of hospital medicine. 11(11):773-777 [DOI] 10.1002/jhm.2619. [PMID] 27256219.
2016
Psychosocial predictors of long-term mortality among women with suspected myocardial ischemia: the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation.
Journal of behavioral medicine. 39(4):687-93 [DOI] 10.1007/s10865-016-9737-7. [PMID] 27017335.
2016
Reply: Association Between Migraine Headache and Cardiac Syndrome X.
Journal of the American College of Cardiology. 67(17) [DOI] 10.1016/j.jacc.2016.01.074. [PMID] 27126542.
2016
Safety of Routine Invasive Versus Selective Invasive Therapy in Women with Non-ST-Elevation Acute Coronary Syndrome.
Cardiology and therapy. 5(1):43-50 [DOI] 10.1007/s40119-015-0055-x. [PMID] 26661893.
2016
The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.
JACC. Basic to translational science. 1(6):510-523 [DOI] 10.1016/j.jacbts.2016.06.010. [PMID] 28580434.
2016
Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women’s ischemia syndrome evaluation (WISE).
Cardiovascular diagnosis and therapy. 6(5):424-431 [PMID] 27747165.
2016
Women, Hypertension, and the Systolic Blood Pressure Intervention Trial.
The American journal of medicine. 129(10):1030-6 [DOI] 10.1016/j.amjmed.2016.06.022. [PMID] 27427323.
2015
Acute kidney injury after transcatheter aortic valve replacement.
American journal of nephrology. 41(4-5):370-1 [DOI] 10.1159/000431340. [PMID] 26113253.
2015
Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child.
Cardiovascular drugs and therapy. 29(4):391-401 [DOI] 10.1007/s10557-015-6597-2. [PMID] 26037616.
2015
Angina treatments and prevention of cardiac events: an appraisal of the evidence.
European heart journal supplements : journal of the European Society of Cardiology. 17(Suppl G):G10-G18 [PMID] 26740801.
2015
Assessing cardiovascular risk in women: looking beyond traditional risk factors.
Trends in cardiovascular medicine. 25(2):152-3 [DOI] 10.1016/j.tcm.2014.10.024. [PMID] 25468290.
2015
Association of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: An ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
American heart journal. 170(6):1243-54 [DOI] 10.1016/j.ahj.2015.08.019. [PMID] 26678647.
2015
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.
Circulation research. 116(1):99-107 [DOI] 10.1161/CIRCRESAHA.116.304710. [PMID] 25406300.
2015
Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women’s Ischemia Syndrome Evaluation.
Circulation. Cardiovascular imaging. 8(4) [DOI] 10.1161/CIRCIMAGING.114.002481. [PMID] 25801710.
2015
Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy.
PloS one. 10(4) [DOI] 10.1371/journal.pone.0122726. [PMID] 25835002.
2015
Efficacy and safety of angiotensin receptor blockers in older patients: a meta-analysis of randomized trials.
American journal of hypertension. 28(5):576-85 [DOI] 10.1093/ajh/hpu209. [PMID] 25391580.
2015
Emergence of Nonobstructive Coronary Artery Disease: A Woman’s Problem and Need for Change in Definition on Angiography.
Journal of the American College of Cardiology. 66(17):1918-33 [DOI] 10.1016/j.jacc.2015.08.876. [PMID] 26493665.
2015
Five-year stroke rate in women with signs and symptoms of ischemia undergoing coronary angiography: a retrospective study from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
JRSM open. 6(3) [DOI] 10.1177/2054270415577761. [PMID] 25893110.
2015
Gut dysbiosis is linked to hypertension.
Hypertension (Dallas, Tex. : 1979). 65(6):1331-40 [DOI] 10.1161/HYPERTENSIONAHA.115.05315. [PMID] 25870193.
2015
Impact of antibiotics on arterial blood pressure in a patient with resistant hypertension – A case report.
International journal of cardiology. 201:157-8 [DOI] 10.1016/j.ijcard.2015.07.078. [PMID] 26301638.
2015
Impact of aspirin according to type of stable coronary artery disease: insights from a large international cohort.
The American journal of medicine. 128(2):137-43 [DOI] 10.1016/j.amjmed.2014.09.028. [PMID] 25447610.
2015
Microvascular coronary dysfunction and ischemic heart disease: where are we in 2014?
Trends in cardiovascular medicine. 25(2):98-103 [DOI] 10.1016/j.tcm.2014.09.013. [PMID] 25454903.
2015
Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
American heart journal. 169(3):412-8 [DOI] 10.1016/j.ahj.2014.12.010. [PMID] 25728732.
2015
Multiple causes for ischemia without obstructive coronary artery disease: not a short list.
Circulation. 131(12):1044-6 [DOI] 10.1161/CIRCULATIONAHA.115.015553. [PMID] 25712204.
2015
PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.
Journal of hypertension. 33(11):2278-85 [DOI] 10.1097/HJH.0000000000000714. [PMID] 26425837.
2015
Recognizing Sex Similarities in Cardiovascular Disease Research.
Journal of the American College of Cardiology. 65(19):2152-3 [DOI] 10.1016/j.jacc.2015.02.066. [PMID] 25975483.
2015
Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation Study.
Cardiovascular endocrinology. 4(2):45-52 [PMID] 26665010.
2015
Renal function and coronary microvascular dysfunction in women with symptoms/signs of ischemia.
PloS one. 10(5) [DOI] 10.1371/journal.pone.0125374. [PMID] 25951606.
2015
The Coronary Microcirculation in STEMI: The Next Frontier?
European heart journal. 36(45):3178-81 [DOI] 10.1093/eurheartj/ehv495. [PMID] 26409009.
2014
2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study.
Journal of the American College of Cardiology. 64(8):784-93 [DOI] 10.1016/j.jacc.2014.05.044. [PMID] 25145522.
2014
2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations.
Journal of the American College of Cardiology. 64(4):394-402 [DOI] 10.1016/j.jacc.2014.06.014. [PMID] 25060376.
2014
A microvascular-myocardial diastolic dysfunctional state and risk for mental stress ischemia: a revised concept of ischemia during daily life.
JACC. Cardiovascular imaging. 7(4):362-5 [DOI] 10.1016/j.jcmg.2013.11.009. [PMID] 24742891.
2014
A Pharmacogenomic Genome-Wide Association Study (Gwas) for New Onset Diabetes (Nod) in the International Verapamil Sr-Trandolapril Study (Invest)
Clinical Pharmacology & Therapeutics. 95(1):S59-S60
2014
A Pharmacogenomic Genome-Wide Association Study (Gwas) for New Onset Diabetes (Nod) in the International Verapamil Sr-Trandolapril Study (Invest)
Clinical Pharmacology & Therapeutics. 95(1):S59-S60
2014
A Pharmacogenomic Genome-Wide Association Study for Adverse Cardiovascular Outcomes in the International Verapamil Sr-Trandolapril Study (Invest)
Clinical Pharmacology & Therapeutics. 95(1)
2014
A training program in cardiovascular cell-based therapy: from the NHLBI Cardiovascular Cell Therapy Research Network.
Regenerative medicine. 9(6):793-7 [DOI] 10.2217/rme.14.57. [PMID] 25431915.
2014
Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women’s ischemia syndrome evaluation.
American heart journal. 167(6):826-32 [DOI] 10.1016/j.ahj.2014.01.017. [PMID] 24890531.
2014
Atp2B1 Locus Is Associated With Resistant Hypertension in the International Verapamil Sr Tandolapril Study-Genetic Substudy (Investgenes)
Clinical Pharmacology & Therapeutics. 95(1):S26-S27
2014
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.
Circulation research. 114(10):1564-8 [DOI] 10.1161/CIRCRESAHA.114.303720. [PMID] 24812350.
2014
Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
Journal of the American Heart Association. 3(1) [DOI] 10.1161/JAHA.113.000660. [PMID] 24584740.
2014
Comparison of low and high dose intracoronary adenosine and acetylcholine in women undergoing coronary reactivity testing: results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
International journal of cardiology. 172(1):e114-5 [DOI] 10.1016/j.ijcard.2013.12.120. [PMID] 24461979.
2014
Depression, dietary habits, and cardiovascular events among women with suspected myocardial ischemia.
The American journal of medicine. 127(9):840-7 [DOI] 10.1016/j.amjmed.2014.04.011. [PMID] 24769297.
2014
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.
Circulation research. 115(10):867-74 [DOI] 10.1161/CIRCRESAHA.115.304353. [PMID] 25136078.
2014
Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension.
Journal of the American Heart Association. 3(6) [DOI] 10.1161/JAHA.114.001398. [PMID] 25385345.
2014
One-year follow-up of intracoronary stem cell delivery on left ventricular function following ST-elevation myocardial infarction.
JAMA. 311(3):301-2 [DOI] 10.1001/jama.2013.282674. [PMID] 24247415.
2014
Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension.
Journal of hypertension. 32(3):635-43 [DOI] 10.1097/HJH.0000000000000051. [PMID] 24299915.
2014
Proceedings from Duke resistant hypertension think tank.
American heart journal. 167(6):775-88.e1 [DOI] 10.1016/j.ahj.2014.02.008. [PMID] 24890525.
2014
Relationships Between Depression, Dietary Habits, and Cardiovascular Mortality and Events Among Women With Suspected Myocardial Ischemia
Psychosomatic Medicine. 76(3)
2014
Reply to ‘Resistant hypertension revisited: definition and true prevalence’.
Journal of hypertension. 32(7) [DOI] 10.1097/HJH.0000000000000220. [PMID] 24984184.
2014
Some thoughts on the continuing dilemma of angina pectoris.
European heart journal. 35(21):1361-4 [DOI] 10.1093/eurheartj/ehs225. [PMID] 23045268.
2014
The prevalence of microvascular dysfunction, its role among men, and links with adverse outcomes: noninvasive imaging reveals the tip of the iceberg.
Circulation. 129(24):2497-9 [DOI] 10.1161/CIRCULATIONAHA.114.010263. [PMID] 24787470.
2014
The Vascular Biology Working Group Twentieth Anniversary
. 35(27):1772-1773
2014
The Vascular Biology Working Group twentieth anniversary.
European heart journal. 35(27):1772-3 [PMID] 25157396.
2014
TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
PloS one. 9(5) [DOI] 10.1371/journal.pone.0096630. [PMID] 24800739.
2014
Usefulness of Beta blockade in contemporary management of patients with stable coronary heart disease.
The American journal of cardiology. 114(10):1607-12 [DOI] 10.1016/j.amjcard.2014.08.026. [PMID] 25260949.
2013
A critical analysis of clinical outcomes reported in stem cell trials for acute myocardial infarction: some thoughts for design of future trials.
Current atherosclerosis reports. 15(8) [DOI] 10.1007/s11883-013-0341-9. [PMID] 23793731.
2013
Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
American heart journal. 166(1):134-41 [DOI] 10.1016/j.ahj.2013.04.002. [PMID] 23816032.
2013
Ankle brachial index values, leg symptoms, and functional performance among community-dwelling older men and women in the lifestyle interventions and independence for elders study.
Journal of the American Heart Association. 2(6) [DOI] 10.1161/JAHA.113.000257. [PMID] 24222666.
2013
Antagonist molecules in the treatment of angina.
Expert opinion on pharmacotherapy. 14(17):2323-42 [DOI] 10.1517/14656566.2013.834329. [PMID] 24047238.
2013
Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation.
International journal of cardiology. 168(3):2335-40 [DOI] 10.1016/j.ijcard.2013.01.036. [PMID] 23410495.
2013
Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis.
Journal of the American College of Cardiology. 61(9):957-70 [DOI] 10.1016/j.jacc.2012.10.051. [PMID] 23352782.
2013
Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment.
The pharmacogenomics journal. 13(5):430-6 [DOI] 10.1038/tpj.2012.34. [PMID] 22907731.
2013
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.
Journal of hypertension. 31(4):698-704 [DOI] 10.1097/HJH.0b013e32835e2a71. [PMID] 23353631.
2013
Body composition changes and cardiometabolic benefits of a balanced Italian Mediterranean Diet in obese patients with metabolic syndrome.
Acta diabetologica. 50(3):409-16 [DOI] 10.1007/s00592-012-0445-7. [PMID] 23188216.
2013
Brachial artery constriction during brachial artery reactivity testing predicts major adverse clinical outcomes in women with suspected myocardial ischemia: results from the NHLBI-sponsored women’s ischemia Syndrome Evaluation (WISE) Study.
PloS one. 8(9) [DOI] 10.1371/journal.pone.0074585. [PMID] 24058592.
2013
Calcium Antagonists in the Treatment of Coronary Artery Disease
Current Opinion in Pharmacology. 13:301-308 [DOI] 10.1016/j.coph.2613.01.008.
2013
Calcium antagonists in the treatment of coronary artery disease.
Current opinion in pharmacology. 13(2):301-8 [DOI] 10.1016/j.coph.2013.01.008. [PMID] 23402734.
2013
Cardiovascular care for women: the 10-Q Report and beyond.
The American journal of cardiology. 112(4) [DOI] 10.1016/j.amjcard.2013.06.002. [PMID] 23910053.
2013
Clinical implications of the Women’s Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomes.
Women's health (London, England). 9(5):479-90 [DOI] 10.2217/whe.13.50. [PMID] 24007253.
2013
Coronary angiography: is it time to reassess?
Circulation. 127(17):1760-2 [DOI] 10.1161/CIRCULATIONAHA.113.002566. [PMID] 23630085.
2013
Detailed analysis of polymer response to delivery balloon expansion of drug-eluting stents versus bare metal stents.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 9(3):389-97 [DOI] 10.4244/EIJV9I3A62. [PMID] 23872653.
2013
Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
Hypertension (Dallas, Tex. : 1979). 62(4):746-52 [DOI] 10.1161/HYPERTENSIONAHA.113.01337. [PMID] 23959549.
2013
Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials.
Clinical Medicine Insights. Cardiology. 7:1-20 [DOI] 10.4137/CMC.S10628. [PMID] 23400444.
2013
Electromechanical Assessment of Myocardial Function (Noga) Is Associated With Exercise Improvement in Patients Treated With Autologous Stem Cell Therapy for Refractory Angina
Journal of the American College of Cardiology. 61
2013
Electromechanical Assessment of Myocardial Function Is Associated With Improvement in Ejection Fraction in Patients Treated With Autologous Stem Cell Therapy for Ischemic Cardiomyopathy
Circulation. 128(22, S)
2013
Enhancing the function of CD34(+) cells by targeting plasminogen activator inhibitor-1.
PloS one. 8(11) [DOI] 10.1371/journal.pone.0079067. [PMID] 24223881.
2013
Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes.
Circulation. Cardiovascular genetics. 6(2):184-92 [DOI] 10.1161/CIRCGENETICS.111.964627. [PMID] 23392654.
2013
Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes.
Pharmacogenetics and genomics. 23(12):697-705 [DOI] 10.1097/FPC.0000000000000012. [PMID] 24128935.
2013
Implementation of cardovascular cell therapy network trials: challenges, innovation and lessons learned from experience in the CCTRN.
Expert review of cardiovascular therapy. 11(11):1495-502 [DOI] 10.1586/14779072.2013.839943. [PMID] 24147517.
2013
Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
Cardiovascular diagnosis and therapy. 3(4):216-27 [DOI] 10.3978/j.issn.2223-3652.2013.10.07. [PMID] 24400205.
2013
Increased wave reflection and ejection duration in women with chest pain and nonobstructive coronary artery disease: ancillary study from the Women’s Ischemia Syndrome Evaluation.
Journal of hypertension. 31(7):1447-54; discussion 1454 [DOI] 10.1097/HJH.0b013e3283611bac. [PMID] 23615325.
2013
Lack of association of the HMGA1 IVS5-13insC variant with type 2 diabetes in an ethnically diverse hypertensive case control cohort.
Journal of translational medicine. 11 [DOI] 10.1186/1479-5876-11-12. [PMID] 23302499.
2013
Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study.
Cardiovascular diagnosis and therapy. 3(2):64-72 [PMID] 24015377.
2013
Loci influencing blood pressure identified using a cardiovascular gene-centric array.
Human molecular genetics. 22(8):1663-78 [DOI] 10.1093/hmg/dds555. [PMID] 23303523.
2013
Mild Renal Insufficiency Predicts Mortality and Adverse Events in Women With Cardiac Ischemia, Independent of the Underlying Obstructive Coronary Artery Disease
Circulation. 128(22, S)
2013
Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST).
Clinical cardiology. 36(8):442-7 [DOI] 10.1002/clc.22145. [PMID] 23720247.
2013
Number and function of bone-marrow derived angiogenic cells and coronary flow reserve in women without obstructive coronary artery disease: a substudy of the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
PloS one. 8(12) [DOI] 10.1371/journal.pone.0081595. [PMID] 24312563.
2013
Oxidative Stress Independently Predicts Diastolic Dysfunction in Women With Signs and Symptoms of Ischemia Without Obstructive Coronary Artery Disease: Results From the Nhlbi-Sponsored Women Ischemia Syndrome Evaluation (Wise)
Circulation. 128(22, S)
2013
Pharmacogenomic association of nonsynonymous SNPs in SIGLEC12, A1BG, and the selectin region and cardiovascular outcomes.
Hypertension (Dallas, Tex. : 1979). 62(1):48-54 [DOI] 10.1161/HYPERTENSIONAHA.111.00823. [PMID] 23690342.
2013
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN).
Circulation. 127(15):1630-5 [DOI] 10.1161/CIRCULATIONAHA.112.000779. [PMID] 23588961.
2013
Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease.
Journal of the American Heart Association. 2(4) [DOI] 10.1161/JAHA.113.000205. [PMID] 23948642.
2013
The Editor’s Roundtable: The 10Q Report – Advancing women’s heart health through improved research, diagnosis, and treatment.
The American journal of cardiology. 112(10):1676-87 [DOI] 10.1016/j.amjcard.2013.09.003. [PMID] 24157193.
2013
The Nhlbi Time Trial: One-Year Results
Circulation. 128(24)
2013
The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation.
Cardiovascular & hematological disorders drug targets. 13(2):99-110 [PMID] 23987998.
2013
Variable and Decreased Clonogenic Activity of Autologous Bone Marrow in Cell Therapy Patients With Ischemic Heart Disease, and Cd34 as a Biomarker for Clinical Outcomes: Results From the Cardiovascular Cell Therapy Research Network (Cctrn)
Circulation. 128(22, S)
2012
A degradable, bioactive, gelatinized alginate hydrogel to improve stem cell/growth factor delivery and facilitate healing after myocardial infarction.
Medical hypotheses. 79(5):673-7 [DOI] 10.1016/j.mehy.2012.08.006. [PMID] 22939314.
2012
Alpha Adducin-1 (Add1)Singlenucleotide Polymorphism (Snp) Associated With New Onset Diabetes Risk With Hydrochlorothiazide (Hctz) Therapy in the International Verapamil Sr Trandolapril Genetic Substudy (Invest-Genes)
Clinical Pharmacology & Therapeutics. 91
2012
An Injectable Acellular Capillary Hydrogel Improves Left Ventricular Function After Myocardial Infarction
Journal of the American College of Cardiology. 59
2012
Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network.
JACC. Cardiovascular imaging. 5(5):559-65 [DOI] 10.1016/j.jcmg.2011.12.018. [PMID] 22595165.
2012
Changes to polymer surface of drug-eluting stents during balloon expansion.
JAMA. 307(20):2148-50 [DOI] 10.1001/jama.2012.4111. [PMID] 22618916.
2012
Cholesteryl Ester Transfer Protein (CETP) polymorphisms affect mRNA splicing, HDL levels, and sex-dependent cardiovascular risk.
PloS one. 7(3) [DOI] 10.1371/journal.pone.0031930. [PMID] 22403620.
2012
Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: The National Heart, Lung, and Blood Institute–sponsored Women’s Ischemia Syndrome Evaluation study.
Psychosomatic medicine. 74(3):263-70 [DOI] 10.1097/PSY.0b013e31824a58ff. [PMID] 22434916.
2012
Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy.
BMC medical research methodology. 12 [DOI] 10.1186/1471-2288-12-119. [PMID] 22866767.
2012
Damage To Polymer Surface and Detachment of Polymer Fragments During Delivery Balloon Expansion of Drug-Eluting Stents: A Previously Unrecognized Source for Adverse Outcomes
Journal of the American College of Cardiology. 59(13, S)
2012
Differential Effects of Cold Pressor and Acetylcholine During Endothelial Function Assessment in Women With No Obstructive Coronary Artery Disease: the Nhlbi-Sponsored Women’S Ischemia Syndrome Evaluation (Wise) Study
Journal of the American College of Cardiology. 59
2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
JAMA. 308(22):2380-9 [PMID] 23129008.
2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
JAMA. 307(16):1717-26 [DOI] 10.1001/jama.2012.418. [PMID] 22447880.
2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study.
Transfusion. 52(10):2225-33 [DOI] 10.1111/j.1537-2995.2011.03543.x. [PMID] 22320233.
2012
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
Hypertension (Dallas, Tex. : 1979). 60(4):957-64 [DOI] 10.1161/HYPERTENSIONAHA.112.198721. [PMID] 22949529.
2012
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci.
American journal of human genetics. 90(3):410-25 [DOI] 10.1016/j.ajhg.2011.12.022. [PMID] 22325160.
2012
Mortality Associated With Angina and Blood Pressure Control Among Hypertensive Patients With Coronary Artery Disease: New Data From Extended Follow-Up of the International Verapamil/Trandolapril Study
Journal of the American College of Cardiology. 59
2012
Mortality Associated With Angina and Blood Pressure Control Among Hypertensive Patients With Coronary Artery Disease: New Data From Extended Follow-Up of the International Verapamil/Trandolapril Study
Journal of the American College of Cardiology. 59
2012
Non-Synonymous Snps in Sele, Selp, and Siglec12 Associate With Cardiovascular (Cv) Outcomes in the International Verapamil Sr-Trandol-April Study Genetic Substudy (Invest-Genes)
Clinical Pharmacology & Therapeutics. 91:S20-S21
2012
Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women.
Journal of women's health (2002). 21(2):133-9 [DOI] 10.1089/jwh.2011.2787. [PMID] 21988550.
2012
Relationships Between Components of Metabolic Syndrome and Coronary Intravascular Ultrasound (Ivus) Atherosclerosis Measures in Women Without Obstructive Coronary Artery Disease: the Nhlbi-Sponsored Women’S Ischemia Syndrome Evaluation (Wise) Study
Journal of the American College of Cardiology. 59(13, S)
2012
Rethinking stable ischemic heart disease: is this the beginning of a new era?
Journal of the American College of Cardiology. 60(11):957-9 [DOI] 10.1016/j.jacc.2012.04.046. [PMID] 22954240.
2012
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women’s Ischemia Syndrome Evaluation) study.
JACC. Cardiovascular interventions. 5(6):646-53 [DOI] 10.1016/j.jcin.2012.01.023. [PMID] 22721660.
2012
Simple Prediction of Long-Term Mortality Among Hypertensive Patients With Coronary Artery Disease: New Data From An Extended Follow-Up of the International Verapamil-Sr/Trandolapril Study (Invest)
Journal of the American College of Cardiology. 59
2012
Treatment of hypertension: lower is better, or is it?
Hypertension (Dallas, Tex. : 1979). 60(2):281-2 [DOI] 10.1161/HYPERTENSIONAHA.112.197632. [PMID] 22753207.
2012
Treatment-Resistant Blood Pressure Among Patients With Coronary Artery Disease – Cause for Concern: New Data From the Extended Follow-Up of the International Verapamail Sr-Trandolapril Study (Invest)
Journal of the American College of Cardiology. 59
2011
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.
Journal of the American College of Cardiology. 57(20):2037-114 [DOI] 10.1016/j.jacc.2011.01.008. [PMID] 21524875.
2011
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.
Journal of the American Society of Hypertension : JASH. 5(4):259-352 [DOI] 10.1016/j.jash.2011.06.001. [PMID] 21771565.
2011
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Circulation. 123(21):2434-506 [DOI] 10.1161/CIR.0b013e31821daaf6. [PMID] 21518977.
2011
Blood pressure lowering in patients with diabetes–one level might not fit all.
Nature reviews. Cardiology. 8(1):42-9 [DOI] 10.1038/nrcardio.2010.182. [PMID] 21079637.
2011
Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease.
Circulation. Cardiovascular genetics. 4(2):169-78 [DOI] 10.1161/CIRCGENETICS.110.959296. [PMID] 21372283.
2011
Could Retinal Imaging Provide a Simple, Inexpensive, Noninvasive Index for Coronary Microvascular Function in Women With Chest Pain and Nonobstructive Coronary Artery Disease? An Ancillary Pilot Study From the Nhlbi-Sponsored Women’s Ischemia Syndrome Evaluation (Wise-Aric)
Journal of the American College of Cardiology. 57
2011
Could Retinal Imaging Provide a Simple, Inexpensive, Noninvasive Index for Coronary Microvascular Function in Women With Chest Pain and Nonobstructive Coronary Artery Disease? An Ancillary Pilot Study From the Nhlbi-Sponsored Women’s Ischemia Syndrome Evaluation (Wise-Aric)
Journal of the American College of Cardiology. 57
2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale.
American heart journal. 162(6):973-80 [DOI] 10.1016/j.ahj.2011.05.024. [PMID] 22137069.
2011
Does Angiotensin Plus Aldosterone Inhibition Improve Coronary Endothelial Function? An Ancillary Study From the Nhlbi-Sponsored Women’s Ischemia Syndrome Evaluation (Wise)
Journal of the American College of Cardiology. 57
2011
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
JAMA. 306(19):2110-9 [DOI] 10.1001/jama.2011.1670. [PMID] 22084195.
2011
Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women’s Ischemia Syndrome Evaluation (WISE) ancillary study.
Clinical cardiology. 34(8):483-7 [DOI] 10.1002/clc.20935. [PMID] 21780138.
2011
Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.
The American journal of cardiology. 107(6):898-905 [DOI] 10.1016/j.amjcard.2010.11.009. [PMID] 21247520.
2011
Genetic Variation in the Calcium Signaling Pathway and Association With Outcomes in Hypertensive Coronary Artery Disease Patients
Clinical Pharmacology & Therapeutics. 89
2011
Genetic Variation in the Calcium Signaling Pathway and Association With Outcomes in Hypertensive Coronary Artery Disease Patients
Clinical Pharmacology & Therapeutics. 89
2011
Harmful effects of NSAIDs among patients with hypertension and coronary artery disease.
The American journal of medicine. 124(7):614-20 [DOI] 10.1016/j.amjmed.2011.02.025. [PMID] 21596367.
2011
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation (WISE).
American heart journal. 162(4):678-84 [DOI] 10.1016/j.ahj.2011.07.011. [PMID] 21982660.
2011
Intramyocardial, autologous CD34+ cell therapy for refractory angina.
Circulation research. 109(4):428-36 [DOI] 10.1161/CIRCRESAHA.111.245993. [PMID] 21737787.
2011
Kcnj1 Snps Are Associated With Increased Fasting Glucose and Risk of New Onset Diabetes During Hctz Therapy
Clinical Pharmacology & Therapeutics. 89
2011
Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study.
Pharmacogenetics and genomics. 21(6):333-40 [DOI] 10.1097/FPC.0b013e3283452fec. [PMID] 21562465.
2011
Microvascular dysfunction: What have we learned from WISE?
Expert review of cardiovascular therapy. 9(12):1491-4 [DOI] 10.1586/erc.11.165. [PMID] 22103866.
2011
Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.
Pharmacogenetics and genomics. 21(1):42-9 [DOI] 10.1097/FPC.0b013e328341e911. [PMID] 21127457.
2011
Quantification of myocardial segmental function in acute and chronic ischemic heart disease and implications for cardiovascular cell therapy trials: a review from the NHLBI-Cardiovascular Cell Therapy Research Network.
JACC. Cardiovascular imaging. 4(6):671-9 [DOI] 10.1016/j.jcmg.2011.02.015. [PMID] 21679903.
2011
Relationship Between Coronary Micro- and Macrovascular Measures in Women With Chest Pain Without Significant Coronary Artery Disease: An Ancillary Substudy From the Nhbli-Sponsored Women’s Ischemia Syndrome Evaluation (Wise)
Journal of the American College of Cardiology. 57
2011
Response To Letter Regarding Article “Chromosome 9P21 Haplotypes and Prognosis in White and Black Patients With Coronary Artery Disease”
Circulation-Cardiovascular Genetics. 4(4) [DOI] 10.1161/CIRCGENETICS.111.960807.
2011
Results From Latetime: a Randomized, Placebo Controlled Trial of Intracoronary Stem Cell Delivery Two To Three Weeks Following Acute Myocardial Infarction
Circulation. 124
2011
Syndrome X and microvascular coronary dysfunction.
Circulation. 124(13):1477-80 [DOI] 10.1161/CIRCULATIONAHA.110.974212. [PMID] 21947935.
2011
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation.
Menopause (New York, N.Y.). 18(9):943-50 [DOI] 10.1097/gme.0b013e3182113672. [PMID] 21532511.
2011
What causes myocardial infarction in women without obstructive coronary artery disease?
Circulation. 124(13):1404-6 [DOI] 10.1161/CIRCULATIONAHA.111.055855. [PMID] 21947933.
2010
A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
American heart journal. 159(6):987.e1-7 [DOI] 10.1016/j.ahj.2010.03.024. [PMID] 20569710.
2010
A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Circulation. Cardiovascular interventions. 3(6):543-8 [DOI] 10.1161/CIRCINTERVENTIONS.110.953885. [PMID] 21062996.
2010
An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE).
Journal of interventional cardiology. 23(6):511-9 [DOI] 10.1111/j.1540-8183.2010.00598.x. [PMID] 21029178.
2010
Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific manner.
PloS one. 5(12) [DOI] 10.1371/journal.pone.0015180. [PMID] 21170323.
2010
Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy.
The American journal of medicine. 123(8):719-26 [DOI] 10.1016/j.amjmed.2010.02.014. [PMID] 20670726.
2010
Bone marrow-derived cells and hypertension.
Expert review of cardiovascular therapy. 8(8):1139-48 [DOI] 10.1586/erc.10.105. [PMID] 20670191.
2010
Clinical Association of Variation in the Beta 2 Regulatory Subunit of the Voltage- Gated Calcium Channel ( Cacnb2) With Outcomes in Hypertensive Coronary Artery Disease ( Cad) Patients.
Clinical Pharmacology & Therapeutics. 87
2010
Clinical Association of Variation in the Beta 2 Regulatory Subunit of the Voltage- Gated Calcium Channel (Cacnb2) With Outcomes in Hypertensive Coronary Artery Disease (Cad) Patients.
Clinical Pharmacology & Therapeutics. 87
2010
Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studies.
Clinical cardiology. 33(10):609-619 [DOI] 10.1002/clc.20830. [PMID] 20960535.
2010
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study.
Journal of the American College of Cardiology. 55(25):2825-32 [DOI] 10.1016/j.jacc.2010.01.054. [PMID] 20579539.
2010
Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]).
The American journal of cardiology. 106(4):498-503 [DOI] 10.1016/j.amjcard.2010.03.056. [PMID] 20691307.
2010
Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).
Journal of cardiovascular translational research. 3(1):30-6 [DOI] 10.1007/s12265-009-9160-3. [PMID] 20445812.
2010
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health–National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
The Journal of clinical endocrinology and metabolism. 95(11):4985-92 [DOI] 10.1210/jc.2010-0143. [PMID] 20739385.
2010
Endothelium as a predictor of adverse outcomes.
Clinical cardiology. 33(12):730-2 [DOI] 10.1002/clc.20854. [PMID] 21184555.
2010
Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES).
Circulation. Cardiovascular genetics. 3(6):548-55 [DOI] 10.1161/CIRCGENETICS.110.957654. [PMID] 21156931.
2010
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group.
Circulation. 121(12):1447-54 [DOI] 10.1161/CIRCULATIONAHA.109.904029. [PMID] 20351302.
2010
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design.
American heart journal. 160(2):215-23 [DOI] 10.1016/j.ahj.2010.03.029. [PMID] 20691824.
2010
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
Texas Heart Institute journal. 37(4):412-20 [PMID] 20844613.
2010
Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience.
Cytotherapy. 12(5):684-91 [DOI] 10.3109/14653249.2010.487900. [PMID] 20524773.
2010
New-Onset Diabetes Risk Associated With Antihypertensive Therapy in Hypertensive Coronary Artery Disease Patients Is Modified By a Single Nucleotide Polymorphism (Snp) in the L-Type Calcium Channel (Ltcc)
Clinical Pharmacology & Therapeutics. 87
2010
Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.
Hypertension (Dallas, Tex. : 1979). 55(1):48-53 [DOI] 10.1161/HYPERTENSIONAHA.109.142240. [PMID] 19996066.
2010
Pathophysiologic mechanisms linking impaired cardiovascular health and neurologic dysfunction: the year in review.
Cleveland Clinic journal of medicine. 77 Suppl 3:S40-5 [DOI] 10.3949/ccjm.77.s3.07. [PMID] 20622075.
2010
Prognostic utility of quantifying evolutionary ST-segment depression on early follow-up electrocardiogram in patients with non-ST-segment elevation acute coronary syndromes.
European heart journal. 31(8):958-66 [DOI] 10.1093/eurheartj/ehp548. [PMID] 20034973.
2010
Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women’s Ischemia Syndrome Evaluation) study.
JACC. Cardiovascular imaging. 3(10):1030-6 [DOI] 10.1016/j.jcmg.2010.07.008. [PMID] 20947048.
2010
Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care.
Annals of medicine. 42(1):19-35 [DOI] 10.3109/07853890903260898. [PMID] 20092398.
2010
Self-rated versus objective health indicators as predictors of major cardiovascular events: the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation.
Psychosomatic medicine. 72(6):549-55 [DOI] 10.1097/PSY.0b013e3181dc0259. [PMID] 20410246.
2010
The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus beta blockers.
Evidence-based medicine. 15(3):92-3 [DOI] 10.1136/ebm1067. [PMID] 20522694.
2010
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
JAMA. 304(1):61-8 [DOI] 10.1001/jama.2010.884. [PMID] 20606150.
2010
Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions.
Diabetes. 59(8):2010-9 [DOI] 10.2337/db10-0287. [PMID] 20460428.
2009
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project.
Archives of internal medicine. 169(9):843-50 [DOI] 10.1001/archinternmed.2009.50. [PMID] 19433695.
2009
CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response.
Circulation. Cardiovascular genetics. 2(4):362-70 [DOI] 10.1161/CIRCGENETICS.109.857839. [PMID] 20031608.
2009
Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.
Journal of the American College of Cardiology. 53(5 Suppl):S28-34 [DOI] 10.1016/j.jacc.2008.10.037. [PMID] 19179214.
2009
Characteristics and outcomes of revascularized patients with hypertension: an international verapamil SR-trandolapril substudy.
Hypertension (Dallas, Tex. : 1979). 53(4):624-30 [DOI] 10.1161/HYPERTENSIONAHA.108.111542. [PMID] 19237684.
2009
Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study.
Psychosomatic medicine. 71(9):958-64 [DOI] 10.1097/PSY.0b013e3181bd6062. [PMID] 19834049.
2009
Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled study.
American heart journal. 157(1):195-203 [DOI] 10.1016/j.ahj.2008.08.027. [PMID] 19081418.
2009
Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies.
Journal of clinical lipidology. 3(2):125-37 [DOI] 10.1016/j.jacl.2009.02.007. [PMID] 21291802.
2009
Genetic and pharmacogenetic associations between NOS3 polymorphisms, blood pressure, and cardiovascular events in hypertension.
American journal of hypertension. 22(7):748-53 [DOI] 10.1038/ajh.2009.81. [PMID] 19407804.
2009
Importance of Blood Pressure Control in Hypertensive Patients With Coronary Heart Disease in Clinical Practice To Reduce the Risk of Stroke Response
Stroke. 40(6) [DOI] 10.1161/STROKEAHA.108.521575.
2009
Incident Or Continued Angina During Hypertension Treatment Is Associated With Increased Risk of Death, Mi, Or Stroke Among Patients With Known Cad: a Substudy of the International Verapamil/Trandolapril Study (Invest)
Circulation. 120:S440-S441
2009
Insulin as a cardiovascular therapeutic: improving glycemic control in patients with coronary artery disease.
Journal of the American College of Cardiology. 53(5 Suppl):S1-2 [DOI] 10.1016/j.jacc.2008.04.074. [PMID] 19179211.
2009
INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.
Expert review of cardiovascular therapy. 7(11):1329-40 [DOI] 10.1586/erc.09.102. [PMID] 19900016.
2009
Long-Term Mortality Associated With New Onset Diabetes in Hypertensive Cad Patients Following Exposure To Antihypertensive Medications: Findings From the International Verapamail Sr-Trandolapril Study (Invest)
Journal of the American College of Cardiology. 53
2009
Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation.
Clinical cardiology. 32(5):244-50 [DOI] 10.1002/clc.20454. [PMID] 19452486.
2009
Noninvasive Pressure Waveform Analysis in Women With Chest Pain and Nonobstructive Coronary Artery Disease
Journal of the American College of Cardiology. 53:A345-A346
2009
Pediatric Atorvastatin in Diabetes Trial (PADIT): a pilot study to determine the effect of atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus.
Journal of Pediatric Endocrinology & Metabolism. 22(1) [PMID] 19344076.
2009
Pediatric Atorvastatin in Diabetes Trial (PADIT): a pilot study to determine the effect of atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus.
Journal of pediatric endocrinology & metabolism : JPEM. 22(1):65-8 [PMID] 19344076.
2009
Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertension.
Clinical pharmacology and therapeutics. 85(1):36-44 [DOI] 10.1038/clpt.2008.194. [PMID] 18946466.
2009
Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
European heart journal. 30(11):1395-401 [DOI] 10.1093/eurheartj/ehp109. [PMID] 19351690.
2009
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.
American heart journal. 158(3):356-63 [DOI] 10.1016/j.ahj.2009.06.009. [PMID] 19699857.
2009
Sudden Cardiac Death and Severity of Obstructive Coronary Artery Disease: a Report From the Nhlbi-Sponsored Women’s Ischemia Syndrome Evaluation (Wise) Study
Circulation. 120
2009
Systolic blood pressure and subjective well-being in patients with coronary artery disease.
Clinical cardiology. 32(11):627-32 [DOI] 10.1002/clc.20501. [PMID] 19711440.
2009
The impact of nitric oxide in cardiovascular medicine: untapped potential utility.
The American journal of medicine. 122(5 Suppl):S10-5 [DOI] 10.1016/j.amjmed.2009.03.003. [PMID] 19393821.
2009
The potential role of nitric oxide in cardiovascular safety when treating patients with osteoarthritis and hypertension: a moderated panel discussion.
The American journal of medicine. 122(5 Suppl):S23-5 [DOI] 10.1016/j.amjmed.2009.03.005. [PMID] 19393823.
2009
Time From Onset of Acute Anterior Myocardial Infarction Negatively Influences Bone Marrow Cell Function: Preliminary Data From the Nhlbi Cctrn Ancillary Studies
Circulation. 120
2009
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
Journal of women's health (2002). 18(9):1315-22 [DOI] 10.1089/jwh.2008.1063. [PMID] 19702477.
2009
Transient Blockade of Tgf-Beta in Hematopoietic Stem Cells and Cd34+Endothelial Precursor Cells Enhances Survival, Proliferation and Reparative Functions in Response To Ischemic Vascular Injury
Circulation. 120
2009
Viral Anti-Inflammatory Treatment of Unstable Coronary Syndromes: the Vt-111 Acute Coronary Syndrome Trial
Circulation. 120
2008
Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation.
Journal of translational medicine. 6 [DOI] 10.1186/1479-5876-6-11. [PMID] 18331634.
2008
Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).
American heart journal. 156(2):397-404 [DOI] 10.1016/j.ahj.2008.03.007. [PMID] 18657677.
2008
beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.
Clinical pharmacology and therapeutics. 84(6):715-21 [DOI] 10.1038/clpt.2008.139. [PMID] 18615004.
2008
Blood pressure targets after high-risk myocardial infarction: is it time to update the guidelines?
Hypertension (Dallas, Tex. : 1979). 51(1):26-7 [PMID] 18039982.
2008
Cacnaic Polymorphisms and Cardiovascular Outcomes in the International Verapamil Sr/Trandolapril Study-Genetic Substudy (Invest-Genes).
Clinical Pharmacology & Therapeutics. 83
2008
Cacnaic Polymorphisms and Cardiovascular Outcomes in the International Verapamil Sr/Trandolapril Study-Genetic Substudy (Invest-Genes).
Clinical Pharmacology & Therapeutics. 83
2008
Clinical and research issues regarding chronic advanced coronary artery disease: part I: Contemporary and emerging therapies.
American heart journal. 155(3):418-34 [DOI] 10.1016/j.ahj.2007.12.004. [PMID] 18294474.
2008
Diabetes Risk Associated With Beta 1-Adrenergic Receptor Polymorphisms Differs By Antihypertensive Drug Therapy: Results From the International Verapamil Sr/Trandolapril Study – Genetic Substudy (Invest-Genes).
Clinical Pharmacology & Therapeutics. 83
2008
Dysglycemia During Treatment With Hctz in Patients With Hypertension and Metabolic Syndrome
Circulation. 118
2008
Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST).
European heart journal. 29(10):1327-34 [DOI] 10.1093/eurheartj/ehn123. [PMID] 18375982.
2008
Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
Journal of women's health (2002). 17(7):1081-92 [DOI] 10.1089/jwh.2007.0596. [PMID] 18774893.
2008
Liver X Receptor-Alpha Gene Variability and Cardiovascular Risk in the International Verapamil Sr/Trandolapril Study – Genetic Substudy (Invest-Genes).
Clinical Pharmacology & Therapeutics. 83
2008
Madd Variants and Risk of Cardiovascular Events in the International Verapamil Sr/Trandolapril Study – Genetic Substudy (Invest Genes).
Clinical Pharmacology & Therapeutics. 83:S82-S83
2008
Madd Variants and Risk of Cardiovascular Events in the International Verapamil Sr/Trandolapril Study – Genetic Substudy (Invest Genes).
Clinical Pharmacology & Therapeutics. 83:S82-S83
2008
Marrow cell therapies for cardiovascular diseases.
Experimental hematology. 36(6):687-94 [DOI] 10.1016/j.exphem.2008.01.012. [PMID] 18375038.
2008
Nos3 Polymorphisms Do Not Associate With Adverse Clinical Outcomes in Elderly Hypertensives With Coronaryartery Disease: Analysis of the International Verapamil Sr-Trandolapril Study Genetic Substudy (Invest-Genes).
Clinical Pharmacology & Therapeutics. 83
2008
Postmarket evaluation of breakthrough technologies.
American heart journal. 156(2):201-8 [DOI] 10.1016/j.ahj.2008.01.036. [PMID] 18657647.
2008
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health–National Heart, Lung, and Blood Institute sponsored Women’s Ischemia Syndrome Evaluation.
The Journal of clinical endocrinology and metabolism. 93(4):1276-84 [DOI] 10.1210/jc.2007-0425. [PMID] 18182456.
2008
Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST.
Stroke. 39(2):343-8 [PMID] 18162623.
2008
Prognostic Significance of Evolving St-Segment Depression On Admission and Early Repeat Electrocardiograms in Non-St Elevation Acute Coronary Syndromes – Insights From the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein Ilb/Illa Inhibitor (Synergy) Trial
Circulation. 118
2008
Provoked coronary spasm and acute coronary syndromes.
Journal of the American College of Cardiology. 52(7):528-30 [DOI] 10.1016/j.jacc.2008.03.065. [PMID] 18687245.
2008
Pulse pressure and adverse outcomes in women: a report from the Women’s Ischemia Syndrome Evaluation (WISE).
American journal of hypertension. 21(11):1224-30 [DOI] 10.1038/ajh.2008.268. [PMID] 18802432.
2008
Response To the J-Point Revisited
Hypertension. 51(5) [DOI] 10.1161/HYPERTENSIONAHA.108.109983.
2008
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
American heart journal. 156(2):241-7 [DOI] 10.1016/j.ahj.2008.02.023. [PMID] 18657652.
2008
Weight Change With Beta-Blocker Use: a Side Effect Put Into Perspective – the Reply
The American journal of medicine. 121(5) [DOI] 10.1016/j.amjmed.2008.01.009.
2007
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.
Circulation. 115(12):1656-95 [PMID] 17372165.
2007
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.
Journal of the American College of Cardiology. 49(12):1376-9 [PMID] 17394978.
2007
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.
Circulation. 115(12):1659-62 [PMID] 17372164.
2007
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.
Journal of the American College of Cardiology. 49(12):1373-412 [PMID] 17394977.
2007
Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.
Blood pressure. Supplement. 1:6-9 [PMID] 17566313.
2007
Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil.
Clinical pharmacology and therapeutics. 81(3):386-91 [PMID] 17339868.
2007
Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study.
Hypertension (Dallas, Tex. : 1979). 50(2):299-305 [PMID] 17606861.
2007
Blood pressure levels on progression of coronary atherosclerosis.
Journal of the American College of Cardiology. 49(12):1369; author reply 1369-70 [PMID] 17394972.
2007
Cardiovascular protection using beta-blockers: a critical review of the evidence.
Journal of the American College of Cardiology. 50(7):563-72 [PMID] 17692739.
2007
Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women’s Ischemia Syndrome Evaluation (WISE).
Clinical cardiology. 30(2):69-74 [PMID] 17326061.
2007
Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
American journal of cardiovascular drugs : drugs, devices, and other interventions. 7 Suppl 1:25-9 [PMID] 19845074.
2007
Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
The American journal of cardiology. 99(11):1549-54 [PMID] 17531579.
2007
Gender differences in the treatment for acute myocardial infarction: bias or biology?
Circulation. 115(7):823-6 [PMID] 17309930.
2007
Influence of Hispanic ethnicity on blood pressure control and cardiovascular outcomes in women with CAD and hypertension: findings from INVEST.
Journal of women's health (2002). 16(5):632-40 [PMID] 17627399.
2007
KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST).
Pharmacogenetics and genomics. 17(9):719-29 [PMID] 17700361.
2007
Metabolic syndrome and cardiovascular disease: challenges and opportunities.
Clinical cardiology. 30(12):593-7 [PMID] 17607758.
2007
Obesity paradox in patients with hypertension and coronary artery disease.
The American journal of medicine. 120(10):863-70 [PMID] 17904457.
2007
Phytoestrogens and coronary microvascular function in women with suspected myocardial ischemia: a report from the Women’s Ischemia Syndrome Evaluation (WISE) Study.
Journal of women's health (2002). 16(4):481-8 [PMID] 17521251.
2007
Raising awareness of angina in women.
Heart (British Cardiac Society). 93(3):279-80 [PMID] 17322502.
2007
Speed, cocaine, and other psychostimulants death rates.
The American journal of cardiology. 100(7) [PMID] 17884386.
2007
Symptom presentation of women with acute coronary syndromes: myth vs reality.
Archives of internal medicine. 167(22):2405-13 [PMID] 18071161.
2007
The editor’s roundtable: chronic stable angina pectoris.
The American journal of cardiology. 100(11):1635-43 [PMID] 18036361.
2007
The pathophysiology of chronic ischemic heart disease.
Clinical cardiology. 30(2 Suppl 1):I4-9 [PMID] 18373328.
2006
An academic-community cardiovascular service line affiliation: design, implementation, and performance.
The American heart hospital journal. 4(2):86-94 [PMID] 16687952.
2006
Anger, hostility, and cardiac symptoms in women with suspected coronary artery disease: the Women’s Ischemia Syndrome Evaluation (WISE) Study.
Journal of women's health (2002). 15(10):1214-23 [PMID] 17199462.
2006
Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients–findings from the International Verapamil SR/Trandolapril Study (INVEST).
American heart journal. 151(5):1072-9 [PMID] 16644338.
2006
Depression is associated with cardiac symptoms, mortality risk, and hospitalization among women with suspected coronary disease: the NHLBI-sponsored WISE study.
Psychosomatic medicine. 68(2):217-23 [PMID] 16554386.
2006
Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study.
Archives of general psychiatry. 63(8):874-80 [PMID] 16894063.
2006
Depressive symptoms in coronary artery disease patients after hypertension treatment.
The Annals of pharmacotherapy. 40(4):597-604 [PMID] 16569807.
2006
Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
Annals of internal medicine. 144(12):884-93 [PMID] 16785477.
2006
Effect of ACAT inhibition on the progression of coronary atherosclerosis.
The New England journal of medicine. 354(12):1253-63 [PMID] 16554527.
2006
Estrogen and different aspects of vascular disease in women and men.
Circulation research. 99(5):459-61 [PMID] 16946140.
2006
Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology.
European heart journal. 27(23):2902-3; author reply 2903 [PMID] 17060344.
2006
Hypertension, menopause, and coronary artery disease risk in the Women’s Ischemia Syndrome Evaluation (WISE) Study.
Journal of the American College of Cardiology. 47(3 Suppl):S50-8 [PMID] 16458172.
2006
Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women’s Ischemia Syndrome Evaluation (WISE) Study.
Journal of the American College of Cardiology. 47(3 Suppl):S44-9 [PMID] 16458171.
2006
Inflammation in atherosclerosis: some thoughts about acute coronary syndromes.
Circulation. 113(17):e728-32 [PMID] 16651475.
2006
Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.
Journal of the American College of Cardiology. 47(3 Suppl):S4-S20 [PMID] 16458170.
2006
Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease.
Journal of the American College of Cardiology. 47(3 Suppl):S21-9 [PMID] 16458167.
2006
Introduction: there is an important need for increased understanding of the pathophysiology of heart failure postinfarction, new treatment strategies, earlier implementation of effective strategies, and more effective use of existing therapies.
The American journal of cardiology. 97(10A):1F-3F [PMID] 16698329.
2006
Ischemic heart disease in women.
Journal of the American College of Cardiology. 47(3 Suppl):S1-3 [PMID] 16458166.
2006
Migraines, angiographic coronary artery disease and cardiovascular outcomes in women.
The American journal of medicine. 119(8):670-5 [PMID] 16887413.
2006
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women’s Ischaemia Syndrome Evaluation (WISE) study.
European heart journal. 27(12):1408-15 [PMID] 16720691.
2006
Phytoestrogens and lipoproteins in women.
The Journal of clinical endocrinology and metabolism. 91(6):2209-13 [PMID] 16595605.
2006
Predictors of adverse outcome among patients with hypertension and coronary artery disease.
Journal of the American College of Cardiology. 47(3):547-51 [PMID] 16458134.
2006
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
The American journal of cardiology. 98(7):890-4 [PMID] 16996868.
2006
Ranolazine is associated with cardiovascular and metabolic improvement: a win-win for patients with diabetes.
European heart journal. 27(1):5-6 [PMID] 16267073.
2006
Some thoughts on the vasculopathy of women with ischemic heart disease.
Journal of the American College of Cardiology. 47(3 Suppl):S30-5 [PMID] 16458168.
2006
The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health–National Heart, Lung, and Blood Institute–sponsored Women’s Ischemia Syndrome Evaluation.
Circulation. 114(9):894-904 [PMID] 16923752.
2006
The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study.
Journal of the American College of Cardiology. 47(3 Suppl):S36-43 [PMID] 16458169.
2005
A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients.
Journal of clinical hypertension (Greenwich, Conn.). 7(11):654-63 [PMID] 16278523.
2005
A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).
Psychosomatic medicine. 67(3):398-406 [PMID] 15911902.
2005
Association between beta-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study.
International journal of obesity (2005). 29(7):746-54 [PMID] 15917856.
2005
Calcium antagonists: effects on cardio-renal risk in hypertensive patients.
Hypertension (Dallas, Tex. : 1979). 46(4):637-42 [PMID] 16172420.
2005
Exercise treadmill testing using a modified exercise protocol in women with suspected myocardial ischemia: findings from the National Heart, Lung and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
American heart journal. 149(3):527-33 [PMID] 15864243.
2005
Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST).
Clinical cardiology. 28(7):321-8 [PMID] 16075824.
2005
Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: a report from the NHLBI-Sponsored WISE Study.
Psychosomatic medicine. 67(4):546-52 [PMID] 16046366.
2005
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease.
American heart journal. 150(1):109-15 [PMID] 16084156.
2005
J curve in hypertension and coronary artery disease.
The American journal of cardiology. 95(1) [PMID] 15619422.
2004
A population-based evaluation of the thrombolysis in myocardial infarction risk score for unstable angina and non-ST elevation myocardial infarction.
Clinical cardiology. 27(2):74-8 [PMID] 14979624.
2004
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE).
Circulation. 109(6):722-5 [PMID] 14970106.
2004
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.
Journal of the American College of Cardiology. 43(8):1375-82 [PMID] 15093870.
2004
Cardiovascular therapies and risk for development of diabetes.
Journal of the American College of Cardiology. 44(3):509-12 [PMID] 15358012.
2004
Characteristics of contemporary patients with hypertension and coronary artery disease.
Clinical cardiology. 27(10):571-6 [PMID] 15553310.
2004
Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.
Hypertension (Dallas, Tex. : 1979). 44(5):637-42 [PMID] 15381674.
2004
Commentary on “new and emerging theories of cardiovascular disease”.
Biological research for nursing. 6(1):17-20; discussion 21 [PMID] 15186704.
2004
Education: nationally achievable solutions.
Clinical cornerstone. 6(3):65-70 [PMID] 15707263.
2004
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
JAMA. 291(3):309-16 [PMID] 14734593.
2004
Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease.
The American journal of cardiology. 93(2):147-53 [PMID] 14715338.
2004
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.
JAMA. 292(1):45-54 [PMID] 15238590.
2004
Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women’s Ischemia Syndrome Evaluation Study.
Journal of the American College of Cardiology. 43(11):2009-14 [PMID] 15172405.
2004
Ischemic heart disease in women: facts and wishful thinking.
Journal of the American College of Cardiology. 43(10):1727-30 [PMID] 15145090.
2004
Ischemic heart disease: metabolic approaches to management.
Clinical cardiology. 27(8):439-41 [PMID] 15346837.
2004
Managing hypertension in European patients with coronary artery disease: design, results, and clinical implications of INVEST.
Italian heart journal : official journal of the Italian Federation of Cardiology. 5(6):411-6 [PMID] 15320564.
2004
Medical malpractice crisis: Florida’s recent experience.
Circulation. 109(24):2936-8 [PMID] 15210608.
2004
Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women’s Ischemia Syndrome Evaluation.
Circulation. 109(6):714-21 [PMID] 14970105.
2004
President’s page: Cardiology without borders: embracing a healthy global association.
Journal of the American College of Cardiology. 44(5):1137-8 [PMID] 15337230.
2004
President’s page: continuing investment in “state-of-the-art” physician education- an ACCF program of high net worth.
Journal of the American College of Cardiology. 43(2):313-4 [PMID] 14736455.
2004
President’s page: Fellow physicians: read, respond, repeat: thoughts on our obligations relative to the media.
Journal of the American College of Cardiology. 43(5):891-2 [PMID] 14998633.
2004
President’s page: members’ benevolence stretches the ACC mission well beyond US borders.
Journal of the American College of Cardiology. 43(4):711-2 [PMID] 14975488.
2004
President’s page: Strengthening our house of cardiology.
Journal of the American College of Cardiology. 43(9):1721-2 [PMID] 15120836.
2004
Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE).
Circulation. 109(24):2993-9 [PMID] 15197152.
2004
Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.
JAMA. 292(10):1179-87 [PMID] 15353530.
2004
Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE).
Circulation. 109(6):726-32 [PMID] 14970107.
2004
Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation study.
Psychosomatic medicine. 66(6):882-8 [PMID] 15564353.
2004
Subliminal editorial conundra confounding publication of multicenter trials.
The American journal of cardiology. 94(10):1268-9 [PMID] 15541242.
2004
Task force 2: Investigator participation in clinical research.
Journal of the American College of Cardiology. 44(8):1729-36 [PMID] 15489116.
2004
Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of coronary disease: the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study.
American heart journal. 147(6):1085-92 [PMID] 15199360.
2004
What is the optimal blood pressure and drug therapy for patients with coronary artery disease?
JAMA. 292(18):2271-3 [PMID] 15536116.
2004
Women’s Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary.
Circulation. 109(6):805-7 [PMID] 14970120.
2004
Women’s Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 1: diagnosis of stable ischemia and ischemic heart disease.
Circulation. 109(6):e44-6 [PMID] 14970123.
2004
Working group 1: How to increase the output of cardiologists.
Journal of the American College of Cardiology. 44(2):233-7 [PMID] 15261910.
2003
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
JAMA. 290(21):2805-16 [PMID] 14657064.
2003
Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.
American heart journal. 146(4):628-34 [PMID] 14564315.
2003
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris.
The American journal of cardiology. 91(3):274-9 [PMID] 12565082.
2003
Creating and adopting an ACC ethical code of conduct.
Journal of the American College of Cardiology. 42(11):2028-9 [PMID] 14662269.
2003
Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.
Journal of the American College of Cardiology. 42(12):2049-59 [PMID] 14680725.
2003
Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: implications for clinical practice.
American heart journal. 145(4):628-35 [PMID] 12679758.
2003
Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study.
Journal of the American College of Cardiology. 41(3):413-9 [PMID] 12575968.
2003
Introduction to “Optimizing management of non-ST-segment elevation acute coronary syndromes”. Harmonizing advances in mechanical and pharmacologic intervention.
Journal of the American College of Cardiology. 41(4 Suppl S):1S-6S [PMID] 12644334.
2003
Introduction: new and emerging implications for the field of vascular biology.
The American journal of cardiology. 91(12A):1H-2H [PMID] 12818728.
2003
Optimizing lipid management in patients with acute coronary syndromes.
The American journal of cardiology. 91(4A):30B-35B [PMID] 12615296.
2003
Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes.
Journal of the American College of Cardiology. 41(4 Suppl S):23S-30S [PMID] 12644337.
2003
President’s page: cardiovascular subspecialties: uniting under a single umbrella to gain strength in support of common interests.
Journal of the American College of Cardiology. 42(9):1685-6 [PMID] 14607461.
2003
President’s page: convocation speech: some thoughts on the future of the cardiovascular specialist and the ACC.
Journal of the American College of Cardiology. 41(7):1229-31 [PMID] 12679227.
2003
President’s page: Counting heads, coming up short: the ratio of cardiologists to patients is becoming inadequate.
Journal of the American College of Cardiology. 42(3):585-7 [PMID] 12906993.
2003
Rethink retirement: plan a second career in cardiology.
Journal of the American College of Cardiology. 42(7):1316-7 [PMID] 14522502.
2003
Socioeconomic status variables predict cardiovascular disease risk factors and prospective mortality risk among women with chest pain. The WISE Study.
Behavior modification. 27(1):54-67 [PMID] 12587260.
2003
The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: an NHLBI WISE study.
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 5(3):475-85 [PMID] 12882078.
2003
The role of carnitine in myocardial dysfunction.
American journal of kidney diseases : the official journal of the National Kidney Foundation. 41(4 Suppl 4):S35-43 [PMID] 12751052.
2003
Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy.
JAMA. 290(21):2831-7 [PMID] 14657067.
2002
Assessment of women with suspected myocardial ischemia: review of findings of the Women’s Ischemia Syndrome Evaluation (WISE) Study.
Current women's health reports. 2(2):110-4 [PMID] 12116599.
2002
Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women’s Ischemia Syndrome Evaluation (WISE).
The American journal of medicine. 113(9):723-7 [PMID] 12517361.
2002
Cyclooxygenase-2 inhibition and cardiovascular events.
Circulation. 106(2):167-9 [PMID] 12105151.
2002
Dobutamine pharmacodynamics during dobutamine stress echocardiography and the impact of beta-blocker withdrawal: a report from the Women’s Ischemic Syndrome Evaluation Study.
Pharmacotherapy. 22(8):939-46 [PMID] 12173796.
2002
Electrocardiogram abnormalities predict angiographic coronary artery disease in women with chest pain: results from the NHLBI WISE Study.
Clinical cardiology. 25(12):553-8 [PMID] 12492124.
2002
Large brachial artery diameter is associated with angiographic coronary artery disease in women.
American heart journal. 143(5):802-7 [PMID] 12040340.
2002
Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: Results from the Psychophysiological Investigations of Myocardial Ischemia study.
Circulation. 105(15):1780-4 [DOI] 10.1161/01.CIR.0000014491.90666.06. [PMID] 11956119.
2002
Pathophysiologic and therapeutic importance of tissue ACE: a consensus report.
Cardiovascular drugs and therapy. 16(2):149-60 [PMID] 12090908.
2002
Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory.
Journal of the American College of Cardiology. 39(9):1456-63 [PMID] 11985907.
2002
Sertraline treatment of major depression in patients with acute MI or unstable angina.
JAMA. 288(6):701-9 [PMID] 12169073.
2001
Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial.
The American journal of cardiology. 88(1):A7, 76-9 [PMID] 11423065.
2001
Carl John Pepine, MD: a conversation with the editor.
The American journal of cardiology. 88(12):1387-402 [PMID] 11741558.
2001
Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study.
American heart journal. 141(5):735-41 [PMID] 11320360.
2001
Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory).
The American journal of cardiology. 87(8):937-41; A3 [PMID] 11305981.
2001
Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia.
The American journal of cardiology. 88(9):1034-7 [PMID] 11704005.
2001
Enhancing clinical trials on the internet: lessons from INVEST.
Clinical cardiology. 24(11 Suppl):V17-23 [PMID] 11712772.
2001
Interventions in cardiology: focus on lipid management in acute and long-term settings.
American Journal of Cardiology. 88(8A):1K-2K [PMID] 11694210.
2001
Introduction: the European INVESTigators meeting.
Clinical cardiology. 24(11 Suppl) [PMID] 11712768.
2001
Psychosocial variables are associated with atherosclerosis risk factors among women with chest pain: the WISE study.
Psychosomatic medicine. 63(2):282-8 [PMID] 11292277.
2001
Sex differences in chest pain in patients with documented coronary artery disease and exercise-induced ischemia: Results from the PIMI study.
American heart journal. 142(5):864-71 [DOI] 10.1067/mhj.2001.119133. [PMID] 11685176.
2001
The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.
The American journal of cardiology. 87(9):1058-63 [PMID] 11348602.
2001
The vascular biology of hypertension and atherosclerosis and intervention with calcium antagonists and angiotensin-converting enzyme inhibitors.
Clinical cardiology. 24(11 Suppl):V1-5 [PMID] 11712769.
2001
Why vascular biology matters.
American Journal of Cardiology. 88(8A):5K-9K [PMID] 11694212.
2000
A renaissance of provocative testing for coronary spasm?
Journal of the American College of Cardiology. 35(7):1857-9 [PMID] 10841235.
2000
Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms.
The New England journal of medicine. 342(12):829-35 [PMID] 10727587.
2000
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
Journal of the American College of Cardiology. 36(3):970-1062 [PMID] 10987629.
2000
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina).
Circulation. 102(10):1193-209 [PMID] 10973852.
2000
American College of Cardiology/ European Society of Cardiology international study of angiographic data compression phase I. The effects of lossy data compression on recognition of diagnostic features in digital coronary angiography.
European heart journal. 21(8):668-78 [PMID] 10731405.
2000
American College of Cardiology/European Society of Cardiology International Study of Angiographic Data Compression Phase I: The effect of lossy data compression on recognition of diagnostic features in digital coronary angiography.
Journal of the American College of Cardiology. 35(5):1370-9 [PMID] 10758987.
2000
Contracted plasma and blood volume in chronic heart failure.
Journal of the American College of Cardiology. 35(1):51-5 [PMID] 10636258.
2000
D-Ribose as a supplement for cardiac energy metabolism.
Journal of cardiovascular pharmacology and therapeutics. 5(4):249-58 [PMID] 11150394.
2000
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study.
Circulation. 102(5):523-30 [PMID] 10920064.
2000
Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Circulation. 102(10):1093-100 [PMID] 10973836.
1999
A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group.
The American journal of cardiology. 84(1):46-50 [PMID] 10404850.
1999
ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions.
Journal of the American College of Cardiology. 33(6):1756-824 [PMID] 10334456.
1999
ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions.
Circulation. 99(17):2345-57 [PMID] 10226103.
1999
American College of Cardiology training statement on recommendations for the structure of an optimal adult interventional cardiology training program: a report of the American College of Cardiology task force on clinical expert consensus documents.
Journal of the American College of Cardiology. 34(7):2141-7 [PMID] 10588237.
1999
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke.
The New England journal of medicine. 340(22):1762-3 [PMID] 10357634.
1999
Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women’s Ischemia Syndrome Evaluation (WISE) study.
Journal of the American College of Cardiology. 33(6):1469-75 [PMID] 10334410.
1999
Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study).
The American journal of cardiology. 84(11):1311-6 [PMID] 10614796.
1999
Digital assessment of the epicardial electrocardiogram: novel methodology for a core laboratory for clinical studies.
Clinical cardiology. 22(4):311-5 [PMID] 10198744.
1999
Dobutamine stress echocardiography in women with chest pain. Pilot phase data from the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation (WISE).
Journal of the American College of Cardiology. 33(6):1462-8 [PMID] 10334409.
1999
Effect of theophylline on the warm-up phenomenon.
The American journal of cardiology. 84(9):1077-80, A9 [PMID] 10569667.
1999
Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease.
The American journal of cardiology. 83(5A):29C-34C [PMID] 10078540.
1999
Factors influencing clinical outcomes after revascularization in the asymptomatic cardiac ischemia pilot (ACIP). ACIP Study Group.
Journal of cardiac surgery. 14(1):1-8 [PMID] 10678439.
1999
Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
Cardiovascular drugs and therapy. 13(3):201-9 [PMID] 10439882.
1999
Low hot pain threshold predicts shorter time to exercise-induced angina: results from the psychophysiological investigations of myocardial ischemia (PIMI) study.
Journal of the American College of Cardiology. 33(7):1855-62 [PMID] 10362185.
1999
Neuroendocrine activation in heart failure is modified by endurance exercise training.
Journal of the American College of Cardiology. 34(4):1170-5 [PMID] 10520808.
1999
Relationship among mental stress-induced ischemia and ischemia during daily life and during exercise: the Psychophysiologic Investigations of Myocardial Ischemia (PIMI) study.
Journal of the American College of Cardiology. 33(6):1476-84 [PMID] 10334411.
1999
The Women’s Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report.
Journal of the American College of Cardiology. 33(6):1453-61 [PMID] 10334408.
1999
Theodore E. Woodward Award. Ischemic heart disease in women: the role of coronary microvascular dysfunction.
Transactions of the American Clinical and Climatological Association. 110:107-16; discussion 117 [PMID] 10344011.
1999
Therapeutic benefit. Aspirin revisited in light of the introduction of clopidogrel.
Stroke. 30(8):1716-21 [PMID] 10436127.
1998
[Coronary stents. Where are we? Where are we going?].
Archivos del Instituto de Cardiologia de Mexico. 68(4):337-45 [PMID] 9810372.
1998
Angina pectoris in a contemporary population: characteristics and therapeutic implications. TIDES Investigators.
Cardiovascular drugs and therapy. 12 Suppl 3:211-6 [PMID] 9800049.
1998
Angiotensin-converting enzyme inhibitors in patients with atherosclerosis and preserved left ventricular function: clinical outcomes.
The Canadian journal of cardiology. 14 Suppl D:23D-26D [PMID] 9713427.
1998
Aspirin and newer orally active antiplatelet agents in the treatment of the post-myocardial infarction patient.
Journal of the American College of Cardiology. 32(4):1126-8 [PMID] 9768742.
1998
Clinical and detailed angiographic findings in patients with ambulatory electrocardiographic ischemia without critical coronary narrowing: results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study.
Clinical cardiology. 21(2):86-92 [PMID] 9491946.
1998
Clinical implications of endothelial dysfunction.
Clinical cardiology. 21(11):795-9 [PMID] 9825190.
1998
Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research Investigators.
Journal of the American College of Cardiology. 31(2):312-20 [PMID] 9462573.
1998
Endothelial dysfunction and its role in the cycle of cardiovascular disease.
The Canadian journal of cardiology. 14 Suppl D:5D-7D [PMID] 9713418.
1998
Heterogeneity among cardiac ischemic and anginal responses to exercise, mental stress, and daily life.
The American journal of cardiology. 82(1):1-6 [PMID] 9670999.
1998
How do we best treat patients with ischemic heart disease?
Circulation. 98(19):1985-6 [PMID] 9808592.
1998
Identifying high yield sources of patients with coronary artery disease for clinical trials: lessons from the Asymptomatic Cardiac Ischemia Pilot (ACIP) experience. The ACIP Study Group.
Clinical cardiology. 21(3):177-82 [PMID] 9541761.
1998
Influence of smoking status on progression of endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
Clinical cardiology. 21(5):331-4 [PMID] 9595215.
1998
Myonecrosis after revascularization procedures.
Journal of the American College of Cardiology. 31(2):241-51 [PMID] 9462562.
1998
Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators.
The New England journal of medicine. 338(25):1785-92 [PMID] 9632444.
1998
Plasma volume changes with an acute bout of high-intensity exercise in men with chronic congestive heart failure secondary to coronary artery disease.
The American journal of cardiology. 81(4):509-13 [PMID] 9485148.
1998
Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.
Journal of the American College of Cardiology. 32(5):1228-37 [PMID] 9809930.
1998
Rationale for ACE inhibition as an anti-ischaemic therapy.
European heart journal. 19 Suppl G:G34-40 [PMID] 9717054.
1998
Systemic hypertension and coronary artery disease.
The American journal of cardiology. 82(3A):21H-24H [PMID] 9719018.
1998
The challenge of managing unstable angina.
European heart journal. 19(2):200-1 [PMID] 9519311.
1998
The effects of angiotensin-converting enzyme inhibition on endothelial dysfunction: potential role in myocardial ischemia.
The American journal of cardiology. 82(10A):23S-27S [PMID] 9860352.
1998
The Psychophysiological Investigations of Myocardial Ischemia (PIMI) study: objective, methods, and variability of measures.
Psychosomatic medicine. 60(1):56-63 [PMID] 9492241.
1998
Use of calcium antagonists in post-myocardial infarction patients.
Journal of the American College of Cardiology. 31(1):118-9 [PMID] 9426028.
1998
Verapamil use in patients with cardiovascular disease: an overview of randomized trials.
Clinical cardiology. 21(9):633-41 [PMID] 9755379.
1997
A detailed angiographic analysis of patients with ambulatory electrocardiographic ischemia: results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) study angiographic core laboratory.
Journal of the American College of Cardiology. 29(1):78-84 [PMID] 8996298.
1997
Anginal status and prediction of cardiac events in patients enrolled in the asymptomatic cardiac ischemia pilot (ACIP) study. ACIP investigators.
The American journal of cardiology. 79(7):889-92 [PMID] 9104900.
1997
Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
Circulation. 95(8):2037-43 [PMID] 9133513.
1997
Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
Journal of the American College of Cardiology. 30(4):955-61 [PMID] 9316524.
1997
Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
The American journal of cardiology. 80(12):1594-7 [PMID] 9416943.
1997
How european cardiologists perceive the role of calcium antagonists in the treatment of unstable angina.
European heart journal. 18 Suppl A:A117-24 [PMID] 9049547.
1997
Improved endothelial function with angiotensin-converting enzyme inhibitors.
The American journal of cardiology. 79(5A):29-32 [PMID] 9127619.
1997
Potential role of angiotensin-converting enzyme inhibition in myocardial ischemia and current clinical trials.
Clinical cardiology. 20(11 Suppl 2):II-58 [PMID] 9422854.
1997
Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study).
The American journal of cardiology. 80(11):1395-401 [PMID] 9399710.
1997
Relation between ambulatory electrocardiographic monitoring and myocardial perfusion imaging to detect coronary artery disease and myocardial ischemia: an ACIP ancillary study. The Asymptomatic Cardiac Ischemia Pilot (ACIP) Investigators.
Journal of the American College of Cardiology. 29(4):764-9 [PMID] 9091522.
1997
Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot study. ACIP Study Group.
Journal of the American College of Cardiology. 29(7):1483-9 [PMID] 9180108.
1997
Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators.
The New England journal of medicine. 337(11):740-7 [PMID] 9287229.
1996
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
Circulation. 94(3):258-65 [PMID] 8759064.
1996
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Relationship between exercise-induced and ambulatory ischemia in patients with stable coronary disease.
Circulation. 94(7):1537-44 [PMID] 8840841.
1996
Calcium antagonists and cardiovascular prognosis: a homogeneous group?
American journal of hypertension. 9(2):99-109 [PMID] 8924271.
1996
Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study).
The American journal of cardiology. 77(15):1302-9 [PMID] 8677870.
1996
Coronary artery stents. American College of Cardiology.
Journal of the American College of Cardiology. 28(3):782-94 [PMID] 8772772.
1996
Does the brain know when the heart is ischemic?
Annals of internal medicine. 124(11):1006-8 [PMID] 8624050.
1996
Effects of A1 adenosine receptor agonism using N6-cyclohexyl-2′-O-methyladenosine in patients with left ventricular dysfunction.
Circulation. 94(6):1212-5 [PMID] 8822971.
1996
Ergonovine echocardiography for coronary spasm: facts and wishful thinking.
Journal of the American College of Cardiology. 27(5):1162-3 [PMID] 8609336.
1996
Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens.
Regulatory peptides. 67(3):137-44 [PMID] 8988513.
1996
Heart rate reduction in the treatment of chronic stable angina pectoris: experiences with a sinus node inhibitor.
American heart journal. 131(1):204-10 [PMID] 8554014.
1996
Ischemic, hemodynamic, and neurohormonal responses to mental and exercise stress. Experience from the Psychophysiological Investigations of Myocardial Ischemia Study (PIMI).
Circulation. 94(10):2402-9 [PMID] 8921780.
1996
Left ventricular, peripheral vascular, and neurohumoral responses to mental stress in normal middle-aged men and women. Reference Group for the Psychophysiological Investigations of Myocardial Ischemia (PIMI) Study.
Circulation. 94(11):2768-77 [PMID] 8941101.
1996
Ongoing clinical trials of angiotensin-converting enzyme inhibitors for treatment of coronary artery disease in patients with preserved left ventricular function.
Journal of the American College of Cardiology. 27(5):1048-52 [PMID] 8609320.
1996
Prognostic implications of silent myocardial ischemia.
The New England journal of medicine. 334(2):113-4 [PMID] 8531943.
1996
Prognostic markers in thrombolytic therapy: looking beyond mortality.
The American journal of cardiology. 78(12A):24-7 [PMID] 8990408.
1996
Relation of patient characteristics to cardiac ischemia during daily life activity (an Asymptomatic Cardiac Ischemia Pilot Data Bank Study).
The American journal of cardiology. 77(15):1267-72 [PMID] 8677864.
1996
What does it mean to improve prognosis of patients with coronary artery disease?
The American journal of cardiology. 77(16):3D-5D [PMID] 8677895.
1995
Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
Journal of the American College of Cardiology. 26(2):305-12 [PMID] 7608428.
1995
Ambulatory ischaemia.
European heart journal. 16(3):297-8 [PMID] 7789369.
1995
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABG.
Circulation. 92(9 Suppl):II1-7 [PMID] 7586390.
1995
Asymptomatic Cardiac Ischemia Pilot (ACIP) study: effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia. The ACIP investigators.
Journal of the American College of Cardiology. 26(3):606-14 [PMID] 7642849.
1995
Asymptomatic Cardiac Ischemia Pilot (ACIP) study: impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes. The ACIP Investigators.
Journal of the American College of Cardiology. 26(3):585-93 [PMID] 7642847.
1995
Asymptomatic cardiac ischemia pilot (ACIP).
Transactions of the American Clinical and Climatological Association. 106:77-83; discussion 83 [PMID] 7483181.
1995
Circadian variation in coronary tone in patients with stable angina. Protective role of the endothelium.
Circulation. 92(11):3201-5 [PMID] 7586304.
1995
Daily life cardiac ischaemia. Should it be treated?
Drugs. 49(2):176-95 [PMID] 7729326.
1995
Effect of calcium antagonists in variant or Prinzmetal angina.
The Canadian journal of cardiology. 11(10):952-6 [PMID] 7489536.
1995
Guidelines for training in adult cardiovascular medicine. Core Cardiology Training Symposium (COCATS). Task Force 3: training in cardiac catheterization and interventional cardiology.
Journal of the American College of Cardiology. 25(1):14-6 [PMID] 7798492.
1995
Lack of long-term ventricular arrhythmia reduction by enalapril in heart failure. SOLVD Investigators.
The American journal of cardiology. 75(17):1244-9 [PMID] 7778548.
1995
The role of calcium antagonists in ischaemic heart disease.
European heart journal. 16 Suppl H:19-24 [PMID] 8846801.
1995
Time-series analysis of long-term ambulatory myocardial ischemia: effects of beta-adrenergic and calcium channel blockade.
American heart journal. 129(4):677-84 [PMID] 7900617.
1994
Adjunctive pharmacologic therapy for acute myocardial infarction.
Clinical cardiology. 17(1 Suppl 1):I10-4 [PMID] 7908862.
1994
Advisory Group reports on silent myocardial ischemia, coronary atherogenesis, and cardiac emergencies. Council for Myocardial Ischemia and Infarction.
The American journal of cardiology. 73(6):39B-44B [PMID] 8141079.
1994
Angiotensin converting enzyme inhibition and coronary artery disease.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension. 12(4):S65-71 [PMID] 7965277.
1994
Characteristics of a contemporary population with angina pectoris. TIDES Investigators.
The American journal of cardiology. 74(3):226-31 [PMID] 8037126.
1994
Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease. Endothelial function revisited.
Circulation. 89(1):45-51 [PMID] 8281679.
1994
Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST).
Circulation. 90(2):762-8 [PMID] 8044945.
1994
Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study.
Journal of the American College of Cardiology. 24(1):11-20 [PMID] 8006252.
1994
Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis?
Circulation. 89(4):1511-7 [PMID] 7908609.
1994
Neutropenia occurring during treatment with vesnarinone (OPC-8212).
The American journal of cardiology. 74(9):968-70 [PMID] 7526678.
1994
The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial.
Journal of the American College of Cardiology. 24(1):1-10 [PMID] 8006249.
1994
Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular Dysfunction.
American heart journal. 128(2):358-64 [PMID] 8037104.
1994
Usefulness of endogenous and exogenous nitric oxide to identify degrees of endothelial dysfunction in patients with stable angina pectoris.
The American journal of cardiology. 74(6):600-3 [PMID] 8074045.
1993
beta-blockers or calcium antagonists in silent ischaemia?
European heart journal. 14 Suppl F:7-14 [PMID] 7903246.
1993
Clinical development of a miniature digital ambulatory ECG transient myocardial ischemia detection system.
Journal of electrocardiology. 26 Suppl:20-4 [PMID] 8189125.
1993
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.
The New England journal of medicine. 329(3):149-55 [PMID] 8515787.
1993
Recommendations for development and maintenance of competence in coronary interventional procedures. American College of Cardiology Cardiac Catheterization Committee.
Journal of the American College of Cardiology. 22(2):629-31 [PMID] 8335841.
1993
Should patients with myocardial ischemia be treated with coronary revascularization?
Coronary artery disease. 4(12):1048-52 [PMID] 8162235.
1993
Silent myocardial ischemia.
Current problems in cardiology. 18(5):301-59 [PMID] 8348834.
1992
Advisory group reports on silent myocardial ischemia, acute intervention after myocardial infarction, and postinfarction management.
The American journal of cardiology. 69(7):41B-46B [PMID] 1543142.
1992
Biology of restenosis and therapeutic approach.
The Surgical clinics of North America. 72(4):919-40 [PMID] 1386690.
1992
Daily life ischemia and nitrate therapy.
The American journal of cardiology. 70(8):54B-63B [PMID] 1529927.
1992
Determinants of isolated systolic hypertension in the elderly.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension. 10(6):S73-7 [PMID] 1432333.
1992
Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.
Lancet (London, England). 340(8829):1173-8 [PMID] 1359258.
1992
Intervention therapy for coronary artery disease in the elderly.
Cardiovascular clinics. 22(2):175-87 [PMID] 1586917.
1992
New insights in measurement of myocardial ischemia.
The American journal of cardiology. 70(17):19G-24G; discussion 25G [PMID] 1449094.
1992
Prevalence of pseudoischemic ST-segment changes during ambulatory electrocardiographic monitoring.
The American journal of cardiology. 70(7):818-20 [PMID] 1519539.
1992
Prinzmetal’s angina (variant angina).
Heart disease and stroke : a journal for primary care physicians. 1(5):281-6 [PMID] 1344118.
1992
Quantitative analysis of nitroglycerin-induced coronary artery vasodilation in transplanted hearts.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 11(5):886-91 [PMID] 1420236.
1992
Serial quantitative coronary angiography in the assessment of coronary disease in the transplanted heart.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 11(3 Pt 2):S52-5 [PMID] 1623000.
1992
Successful use of low-dose tissue plasminogen activator for treatment of thrombosed prosthetic valve in a 22-month-old child.
American heart journal. 124(3):783-5 [PMID] 1514510.
1992
Treatment strategies for daily life silent myocardial ischemia: a correlation with potential pathogenic mechanisms.
Progress in cardiovascular diseases. 35(2):97-118 [PMID] 1355607.
1992
Ventricular/vascular interaction in health and heart failure.
Comprehensive therapy. 18(7):12-9 [PMID] 1424523.
1991
ACC/AHA guidelines for cardiac catheterization and cardiac catheterization laboratories. American College of Cardiology/American Heart Association Ad Hoc Task Force on Cardiac Catheterization.
Circulation. 84(5):2213-47 [PMID] 1934395.
1991
Circadian variations in myocardial ischemia. Implications for management.
JAMA. 265(3):386-90 [PMID] 1984540.
1991
Effectiveness of percutaneous balloon valvuloplasty in adults with pulmonic valve stenosis.
The American journal of cardiology. 68(10):1111-3 [PMID] 1927933.
1991
Effects of atenolol alone, nifedipine alone and their combination on ambulant myocardial ischemia.
The American journal of cardiology. 67(8):671-5 [PMID] 2006616.
1991
New thoughts of pathophysiology and therapy of ischemic heart disease.
Cardiologia (Rome, Italy). 36(12 Suppl 1):373-7 [PMID] 1841793.
1991
Restenosis after angioplasty.
Medical Section proceedings : the … annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting. 77-84 [PMID] 1821949.
1991
Sudden death during ambulatory electrocardiographic monitoring.
The American journal of cardiology. 68(8):785-8 [PMID] 1892087.
1991
The prognostic and economic implications of a strategy to detect and treat asymptomatic ischemia: the Atenolol Silent Ischemia Trial (ASIST) protocol.
Clinical cardiology. 14(6):457-62 [PMID] 1810681.
1991
The therapeutic potential of carnitine in cardiovascular disorders.
Clinical therapeutics. 13(1):2-21; discussion 1 [PMID] 2029724.
1991
Therapeutic implications of circadian variations in myocardial ischemia and related physiologic functions.
American journal of hypertension. 4(7 Pt 2):442S-448S [PMID] 1680345.
1991
Unrecognized left ventricular dysfunction in an apparently healthy alcohol abuse population.
Drug and alcohol dependence. 28(2):113-9 [PMID] 1935563.
1990
A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group.
Circulation. 81(6):1753-61 [PMID] 2188753.
1990
Acute antianginal hemodynamic effects of nicardipine in coronary artery disease.
American heart journal. 119(2 Pt 2):457-62 [PMID] 2301244.
1990
Ambulant myocardial ischemia and its prognostic implications.
Circulation. 81(3):1136-8 [PMID] 2306819.
1990
Application of time series analysis to circadian rhythms: effect of beta-adrenergic blockade upon heart rate and transient myocardial ischemia.
The American journal of cardiology. 66(16):22G-24G [PMID] 2239708.
1990
Cardiovascular effects of nicardipine.
Angiology. 41(11 Pt 2):978-86 [PMID] 2248426.
1990
Clinical effects of calcium antagonists in silent ischemia.
Journal of cardiovascular pharmacology. 16 Suppl 2:S9-12 [PMID] 1369708.
1990
Effects of intracoronary ergonovine on the contralateral coronary artery in patients with atypical chest pain.
The American journal of cardiology. 66(19):1383-5 [PMID] 2244575.
1990
Effects of nicardipine on myocardial function in vitro and in vivo.
Circulation. 81(2 Suppl):III139-47 [PMID] 2297878.
1990
Is silent ischemia a treatable risk factor in patients with angina pectoris?
Circulation. 82(3 Suppl):II135-42 [PMID] 2203559.
1990
Occlusion after coronary revascularization.
Journal of the American College of Cardiology. 15(6):1259-60 [PMID] 2329229.
1990
The cardiac catheterization laboratory–1990.
The American journal of cardiology. 66(14):37F-40F [PMID] 2239699.
1990
The importance of timing of thrombolytic therapy as shown in clinical trials.
Clinical cardiology. 13(8 Suppl 8):VIII12-7 [PMID] 2119925.
1990
The M-Heart percutaneous balloon mitral Valvuloplasty Registry: initial results and early follow-up. The M-Heart Group.
Journal of the American College of Cardiology. 15(6):1221-6 [PMID] 2184182.
1990
Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population.
Clinical cardiology. 13(5):323-8 [PMID] 2347124.
1990
Videodensitometry versus digital calipers for quantitative coronary angiography.
The American journal of cardiology. 66(17):1186-90 [PMID] 2239720.
1989
Cardiovascular reactivity and silent ischemia in response to mental stress in symptomatic and asymptomatic coronary artery disease patients: results of a pilot study.
Clinical cardiology. 12(11):634-8 [PMID] 2582655.
1989
Coronary artery spasm and acute myocardial infarction.
Cardiovascular clinics. 20(1):131-40 [PMID] 2496919.
1989
Effects of intravenous and intracoronary nicardipine.
The American journal of cardiology. 64(15):8H-15H [PMID] 2801574.
1989
Influence of beta-adrenergic blockade defined by time series analysis on circadian variation of heart rate and ambulatory myocardial ischemia.
The American journal of cardiology. 64(14):835-9 [PMID] 2801549.
1989
New concepts in the pathophysiology of acute myocardial infarction.
The American journal of cardiology. 64(4):2B-8B [PMID] 2665468.
1989
New concepts in the pathophysiology of acute myocardial ischemia and infarction and their relevance to contemporary management.
Cardiovascular clinics. 20(1):3-18 [PMID] 2653640.
1989
Nicardipine, a new calcium channel blocker: role for vascular selectivity.
Clinical cardiology. 12(5):240-6 [PMID] 2656020.
1988
Ambulatory ECG (Holter) monitoring in management of acute myocardial ischemia.
Cardiovascular clinics. 18(3):7-22 [PMID] 3282667.
1988
Beta-adrenergic blockers in silent myocardial ischemia.
The American journal of cardiology. 61(3):18B-21B [PMID] 2893528.
1988
Coronary artery spasm and its relationship to exercise in patients without severe coronary obstructive disease.
Clinical cardiology. 11(7):489-94 [PMID] 3416514.
1988
Effects of nicardipine on coronary blood flow.
American heart journal. 116(1 Pt 1):248-54 [PMID] 3293393.
1988
Effects of transient increase in intrathoracic pressure on hemodynamic determinants of myocardial oxygen supply and demand.
Clinical cardiology. 11(12):831-7 [PMID] 3233813.
1988
Hemodynamic effects of high versus low-osmolar contrast media for ventriculography in severe aortic stenosis.
Cardiovascular and interventional radiology. 11(1):10-3 [PMID] 3130990.
1988
Intravenous nicardipine: cardiovascular effects and clinical relevance.
Clinical therapeutics. 10(3):316-25 [PMID] 3078910.
1988
Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease.
The American journal of cardiology. 61(1):65-70 [PMID] 3337018.
1988
Restenosis following coronary artery angioplasty: patterns, recognition, and results of repeat angioplasty.
Cardiovascular clinics. 19(2):233-51 [PMID] 2972377.
1988
Silent myocardial ischemia.
Annual review of medicine. 39:213-9 [PMID] 3285773.
1988
Silent myocardial ischemia. Rationale for management.
Postgraduate medicine. Spec No:76-82 [PMID] 2894663.
1987
Angiographic morphology of restenosis after percutaneous transluminal coronary angioplasty.
The American journal of cardiology. 60(1):50-4 [PMID] 2955692.
1987
Comparison of diltiazem and nifedipine alone and in combination in patients with coronary artery spasm.
Journal of the American College of Cardiology. 9(2):412-9 [PMID] 3543092.
1987
Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
The American journal of cardiology. 60(4):244-8 [PMID] 2887101.
1987
Effect of nicardipine on determinants of myocardial ischemia occurring during acute coronary occlusion produced by percutaneous transluminal coronary angioplasty.
The American journal of cardiology. 60(4):267-70 [PMID] 2441586.
1987
Effects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectoris.
The American journal of cardiology. 60(7):471-6 [PMID] 3630928.
1987
Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease.
The American journal of cardiology. 60(7):519-24 [PMID] 3630934.
1987
Fatal hydrofluoric acid cutaneous exposure with refractory ventricular fibrillation.
The Journal of burn care & rehabilitation. 8(3):216-9 [PMID] 3649345.
1987
Management of the total ischemic burden in angina pectoris.
The American journal of cardiology. 59(7):7C-12C [PMID] 3825929.
1987
Medical therapy for silent myocardial ischemia.
Circulation. 75(3 Pt 2):II43-4 [PMID] 2880679.
1987
Palliative balloon valvuloplasty for calcific aortic stenosis in the elderly.
The Journal of the Florida Medical Association. 74(6):402-4 [PMID] 2444668.
1987
Patient with coronary artery spasm and role of the critical care nurse.
Heart & lung : the journal of critical care. 16(4):392-402 [PMID] 3298167.
1987
Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty.
The American journal of cardiology. 60(3):56B-60B [PMID] 2956845.
1987
Recognition and management of myocardial ischemia.
Comprehensive therapy. 13(4):6-11 [PMID] 2882886.
1987
Relation of transient silent ischemic episodes to daily activities.
Circulation. 75(3 Pt 2):II28-30 [PMID] 3815785.
1987
Silent myocardial ischemia during daily activities in asymptomatic men with positive exercise test responses.
The American journal of cardiology. 59(1):45-9 [PMID] 3812251.
1987
Systemic and coronary hemodynamic effects of combined intravenous diltiazem and nitroglycerin administration.
American heart journal. 113(6):1376-82 [PMID] 3109225.
1987
Therapeutic implications of silent myocardial ischemia during daily activity.
The American journal of cardiology. 59(9):993-5 [PMID] 3565290.
1987
Usefulness of nicardipine for angina pectoris.
The American journal of cardiology. 59(17):13J-19J [PMID] 3300237.
1986
Ambulatory ECG monitoring. How useful in detecting and quantitating transient ischemia?
Postgraduate medicine. 79(1):141-2, 144, 146 [PMID] 3941814.
1986
Clinical aspects of silent myocardial ischemia in patients with angina and other forms of coronary heart disease.
The American journal of medicine. 80(4C):25-34 [PMID] 2871755.
1986
Clinical aspects of silent myocardial ischemia. Effects of treatment.
Chest. 90(6):906-11 [PMID] 3536344.
1986
Coronary angioplasty at the time of initial cardiac catheterization.
Catheterization and cardiovascular diagnosis. 12(4):219-22 [PMID] 2944592.
1986
Detection of silent myocardial ischemia in patients with angina using continuous electrocardiographic monitoring.
Cardiology clinics. 4(4):627-33 [PMID] 3779724.
1986
Effect of propranolol on myocardial ischemia occurring during acute coronary occlusion.
Circulation. 73(4):727-33 [PMID] 2936533.
1986
Effects of diltiazem during tachycardia-induced angina pectoris.
The American journal of cardiology. 57(1):10-4 [PMID] 3942050.
1986
Effects of nicardipine on left ventricular function and energetics in man.
International journal of cardiology. 10(3):237-50 [PMID] 3957469.
1986
Laser angioplasty with angioscopic guidance in humans.
Journal of the American College of Cardiology. 8(1):184-92 [PMID] 3711515.
1986
Left ventricular dyskinesia reversed by intravenous nitroglycerin: a manifestation of silent myocardial ischemia.
The American journal of cardiology. 58(4):38B-42B [PMID] 3092612.
1986
Left ventricular function abnormalities as a manifestation of silent myocardial ischemia.
Cardiology clinics. 4(4):669-75 [PMID] 3536095.
1986
Low-frequency requirements for recording ischemic ST-segment abnormalities in coronary artery disease.
The American journal of cardiology. 58(3):225-9 [PMID] 3739909.
1986
Myocardial ischemia and chest pain: a misunderstood and oversimplified relationship?
Cardiology clinics. 4(4):621-5 [PMID] 3779723.
1986
Percutaneous transluminal coronary angioplasty in evolving acute myocardial infarction.
The American journal of cardiology. 57(13):1069-74 [PMID] 2939705.
1986
Pharmacodynamic aspects of intravenous diltiazem administration.
American heart journal. 111(1):54-61 [PMID] 3946159.
1986
Silent myocardial ischemia during daily activities: studies in asymptomatic patients and those with various forms of angina.
Cardiology clinics. 4(4):635-42 [PMID] 3779725.
1986
Silent myocardial ischemia: definition, magnitude, and scope of the problem.
Cardiology clinics. 4(4):577-81 [PMID] 3779718.
1986
Tetraethylammonium-induced phasic arterial constriction: temporal and spatial characteristics.
The American journal of physiology. 251(2 Pt 2):H436-42 [PMID] 3740296.
1986
Transluminal laser irradiation of coronary arteries in live dogs: an angiographic and morphologic study of acute effects.
The American journal of cardiology. 57(1):171-4 [PMID] 3942064.
1986
Treatment of silent myocardial ischemia.
Cardiology clinics. 4(4):685-96 [PMID] 3536096.
1986
Ventricular/vascular interaction in patients with mild systemic hypertension and normal peripheral resistance.
Circulation. 74(3):455-62 [PMID] 3742748.
1985
A modified catheter system for retrograde left ventricular catheterization in aortic valve stenosis.
Catheterization and cardiovascular diagnosis. 11(4):433-9 [PMID] 4042159.
1985
Calcium antagonists.
Cardiology. 72(5-6):297-321 [PMID] 2866840.
1985
Clinical and angiographic experience with intraoperative transluminal balloon-catheter dilatation and coronary artery bypass graft surgery.
The Journal of cardiovascular surgery. 26(3):207-11 [PMID] 3158662.
1985
Coronary and systemic hemodynamic effects of nicardipine.
The American journal of cardiology. 55(6):652-6 [PMID] 3976506.
1985
Coronary artery collateral visualization during acute coronary occlusion.
The American journal of cardiology. 55(9):1216-8 [PMID] 3157311.
1985
Coronary hemodynamic responses during spontaneous angina in patients with and patients without coronary artery spasm.
The American journal of cardiology. 56(1):41-6 [PMID] 4014038.
1985
Effect of nifedipine on coronary hemodynamics in patients with left anterior descending coronary occlusion.
Journal of the American College of Cardiology. 5(2 Pt 1):318-25 [PMID] 3968317.
1985
Effects of age on ventricular-vascular coupling.
The American journal of cardiology. 55(9):1179-84 [PMID] 3984897.
1985
Effects of muscle contraction on pulsatile pressure-flow relations in femoral bed.
Journal of applied physiology (Bethesda, Md. : 1985). 58(4):1128-35 [PMID] 3988669.
1985
Emergency coronary artery bypass graft surgery for threatened acute myocardial infarction related to coronary artery catheterization.
The Annals of thoracic surgery. 39(2):116-24 [PMID] 3155937.
1985
Importance of imaging plane for magnetic resonance imaging of the normal left ventricle.
The American journal of cardiology. 56(4):366-72 [PMID] 4025180.
1985
In vitro effects of argon laser radiation on blood: quantitative and morphologic analysis.
Journal of the American College of Cardiology. 5(2 Pt 1):231-7 [PMID] 3968308.
1985
Isosorbide dinitrate and nifedipine in variant angina pectoris.
American heart journal. 110(1 Pt 2):251-6 [PMID] 3925744.
1985
Laser recanalization of occluded atherosclerotic arteries in vivo and in vitro.
Circulation. 71(2):403-11 [PMID] 3965181.
1985
Multivessel coronary spasm without electrocardiographic changes.
American heart journal. 110(5):1064-7 [PMID] 4061259.
1985
Myocardial infarction.
Medical Section proceedings : the … annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting. 33-9 [PMID] 3836408.
1985
Myocardial ischemia during intravenous nicardipine administration.
The American journal of cardiology. 55(6):844-5 [PMID] 3976532.
1985
Nicardipine for angina pectoris at rest and coronary arterial spasm.
The American journal of cardiology. 56(4):232-6 [PMID] 3927691.
1985
Non-surgical strategies to prevent death in coronary artery disease.
Medical Section proceedings : the … annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting. 19-28 [PMID] 2941755.
1985
Prevention of vasospastic angina with nicardipine.
British journal of clinical pharmacology. 20 Suppl 1(Suppl 1):187S-194S [PMID] 3896281.
1985
Proposed: cardiac catheterization should be routine after acute myocardial infarction to evaluate prognosis and plan therapy.
Hospital practice (Office ed.). 20(2):131-2, 134, 138 [PMID] 3918058.
1985
Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4.
Journal of the American College of Cardiology. 6(5):1047-51 [PMID] 4045029.
1985
Regional coronary hemodynamic responses during the cold pressor test: lack of effect of nitroglycerin.
Journal of the American College of Cardiology. 5(6):1319-25 [PMID] 3923076.
1985
Sustained benefit of verapamil in pulmonary hypertension with progressive systemic sclerosis.
American heart journal. 109(2):380-2 [PMID] 3966362.
1985
Systemic, left ventricular and coronary hemodynamic effects of intravenous diltiazem in coronary artery disease.
The American journal of cardiology. 56(7):413-7 [PMID] 4036821.
1985
The healing process in normal canine arteries and in atherosclerotic monkey arteries after transluminal laser irradiation.
The American journal of cardiology. 56(15):983-8 [PMID] 4072933.
1984
A new model for investigation of transluminal recanalization: human atherosclerotic coronary artery xenografts.
The American journal of cardiology. 54(1):200-5 [PMID] 6741814.
1984
A temporary external DDD pacing unit.
The American journal of cardiology. 53(8):1041-3 [PMID] 6702681.
1984
AV block induced by drinking cold liquids.
American heart journal. 108(4 Pt 1):1054-6 [PMID] 6485992.
1984
Clinical evaluation of a new temporary atrial pacing catheter: results in 100 patients.
American heart journal. 107(2):237-40 [PMID] 6364754.
1984
Comprehensive drug management of angina pectoris.
Cardiovascular clinics. 14(3):139-51 [PMID] 6144388.
1984
Detection of transient ischemic episodes by ambulatory ECG recordings.
Cardiology clinics. 2(3):441-8 [PMID] 6399873.
1984
Effect of nitroglycerin on coronary collateral flow and pressure during acute coronary occlusion.
The American journal of cardiology. 54(8):958-63 [PMID] 6437205.
1984
Effects of acute coronary occlusion on hemodynamics in an adjacent coronary artery in dogs.
The American journal of cardiology. 54(8):1103-7 [PMID] 6496331.
1984
Effects of bepridil on exercise tolerance in chronic stable angina: a double-blind, randomized, placebo-controlled, crossover trial.
The American journal of cardiology. 53(6):679-83 [PMID] 6367414.
1984
Effects of bepridil on the resting electrocardiogram.
International journal of cardiology. 6(3):319-23 [PMID] 6384070.
1984
Evaluation of coronary collateral circulation in conscious humans.
The American journal of cardiology. 53(9):1233-8 [PMID] 6231848.
1984
Hemodynamic effects of nitroglycerin combined with diltiazem in patients with coronary artery disease.
The American journal of medicine. 76(6A):47-51 [PMID] 6430077.
1984
Intracoronary streptokinase in evolving acute myocardial infarction.
American heart journal. 107(4):823-5 [PMID] 6367408.
1984
Intraoperative balloon-catheter dilatation: University of Florida experience.
American heart journal. 107(4):841-4 [PMID] 6230914.
1984
Left ventricular changes resulting from chronic aortic regurgitation in dogs.
The American journal of cardiology. 54(7):890-2 [PMID] 6237570.
1984
Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment.
Lancet (London, England). 1(8389) [PMID] 6145002.
1984
Percutaneous brachial catheterization using a modified sheath and new catheter system.
Catheterization and cardiovascular diagnosis. 10(6):637-42 [PMID] 6509548.
1984
Percutaneous transluminal coronary angioplasty in acute myocardial infarction.
American heart journal. 107(4):820-2 [PMID] 6230910.
1984
Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin.
Clinical pharmacology and therapeutics. 36(6):765-72 [PMID] 6437723.
1984
Retrograde catheterization of left ventricle through tilting disc valves using a modified catheter system.
The American journal of cardiology. 54(10):1372-4 [PMID] 6507318.
1984
ST-segment alternans during percutaneous transluminal coronary angioplasty.
The American journal of cardiology. 54(7):915-6 [PMID] 6237571.
1984
Thromboembolic complications of coronary angioplasty.
The American journal of cardiology. 54(7):916-7 [PMID] 6237572.
1983
Analysis of coronary responses to nifedipine alone and in combination with intracoronary nitroglycerin in patients with coronary artery disease.
American heart journal. 105(4):651-8 [PMID] 6404148.
1983
Clinical outcome after treatment of rest angina with calcium blockers: comparative experience during the initial year of therapy with diltiazem, nifedipine, and verapamil.
American heart journal. 106(6):1341-7 [PMID] 6359845.
1983
Comparison of coronary hemodynamic effects of nitroprusside and sublingual nitroglycerin with anterior descending coronary arterial occlusion.
The American journal of cardiology. 52(8):915-20 [PMID] 6416045.
1983
Comparison of early and long-term results with intraoperative transluminal balloon catheter dilatation and coronary artery bypass grafting.
The Journal of thoracic and cardiovascular surgery. 86(3):435-40 [PMID] 6224982.
1983
Comparison of the effects of nitroprusside and nitroglycerin on coronary size.
Catheterization and cardiovascular diagnosis. 9(4):391-9 [PMID] 6414717.
1983
Coronary arterial aneurysm formation after balloon angioplasty.
The American journal of cardiology. 52(3):261-4 [PMID] 6223521.
1983
Dynamic coronary blood flow reduction: supply side considerations.
International journal of cardiology. 3(1):3-13 [PMID] 6343260.
1983
Effect of glyceryl trinitrate on coronary and systemic hemodynamics in man.
The American journal of medicine. 74(6B):28-32 [PMID] 6407313.
1983
Electrocardiographic changes with coronary artery spasm.
American heart journal. 106(6):1288-97 [PMID] 6650351.
1983
Evaluation of coronary artery stenoses.
International journal of cardiology. 4(2):185-7 [PMID] 6629532.
1983
Indices of ventricular contractile state: comparative sensitivity and specificity.
American heart journal. 106(1 Pt 1):136-44 [PMID] 6191558.
1983
Influence of acute aortic insufficiency on the hemodynamic importance of a coronary artery narrowing. II. Various magnitudes of aortic insufficiency.
Journal of the American College of Cardiology. 1(5):1281-9 [PMID] 6833667.
1983
Influence of aortic stenosis on the hemodynamic importance of coronary artery narrowing in dogs without left ventricular hypertrophy.
The American journal of cardiology. 51(5):865-71 [PMID] 6219570.
1983
Long-term oral verapamil therapy in patients with rest angina.
American heart journal. 106(5 Pt 1):1133-7 [PMID] 6416042.
1983
Long-term responses to nifedipine in patients with coronary spasm who have an initial favorable response.
The American journal of cardiology. 52(1):26-9 [PMID] 6858922.
1983
Multiple versus single coronary arterial stenosis: hemodynamic differences.
The American journal of cardiology. 52(5) [PMID] 6613901.
1983
Pacemaker-mediated tachycardias: a rapid bedside technique for induction and observation.
The American journal of cardiology. 52(3):287-91 [PMID] 6869274.
1983
Quantitative coronary angiography during intracoronary streptokinase in acute myocardial infarction: how long to continue thrombolytic therapy?
Catheterization and cardiovascular diagnosis. 9(1):9-18 [PMID] 6403248.
1983
Regional coronary venous flow responses to transient coronary artery occlusion in human beings.
Journal of the American College of Cardiology. 2(1):1-10 [PMID] 6222103.
1983
The clinical syndrome of variant angina.
Cardiovascular clinics. 14(1):59-69 [PMID] 6352029.
1983
The role of coronary artery spasm in exercise-induced angina.
Cardiovascular clinics. 14(1):81-6 [PMID] 6352030.
1983
Titrates for treatment of unstable angina pectoris and coronary vasospasm.
The American journal of medicine. 74(6B):40-4 [PMID] 6134468.
1983
What is the role of coronary artery spasm in ischemic heart disease?
Cardiovascular clinics. 13(1):131-46 [PMID] 6336665.
1982
Action of intracoronary nitroglycerin in refractory coronary artery spasm.
Circulation. 65(2):411-4 [PMID] 6797753.
1982
Analysis of coronary responses to various doses of intracoronary nitroglycerin.
Circulation. 66(2):321-7 [PMID] 6807566.
1982
Aortic input impedance in cardiovascular disease.
Progress in cardiovascular diseases. 24(4):307-18 [PMID] 7054859.
1982
Coronary artery spasm: prevalence, clinical significance, and provocative testing.
American heart journal. 103(4 Pt 2):584-8 [PMID] 7064801.
1982
Diltiazem: a review of its clinical efficacy and use.
Drug intelligence & clinical pharmacy. 16(5):371-9 [PMID] 7044736.
1982
Effects of selective injection of contrast media on coronary artery diameter.
Catheterization and cardiovascular diagnosis. 8(6):547-52 [PMID] 7151152.
1982
Ergonovine-induced esophageal spasm in patients with chest pain resembling angina pectoris.
Digestive diseases and sciences. 27(12):1073-80 [PMID] 7172956.
1982
Intracoronary propylene glycol.
The New England journal of medicine. 306(14):868-9 [PMID] 7062967.
1982
Left ventricular afterload and aortic input impedance: implications of pulsatile blood flow.
Progress in cardiovascular diseases. 24(4):293-306 [PMID] 7054858.
1982
Percutaneous balloon valvuloplasty for pulmonic valve stenosis in the adult.
The American journal of cardiology. 50(6):1442-5 [PMID] 6216808.
1982
Preliminary experience with intraoperative transluminal balloon-catheter dilation and coronary artery bypass grafting for the treatment of symptomatic diffuse coronary artery disease.
The Annals of thoracic surgery. 34(5):504-14 [PMID] 6215899.
1982
Randomized double-blind comparison of nifedipine and isosorbide dinitrate in patients with coronary arterial spasm.
The American journal of cardiology. 49(2):431-8 [PMID] 6800251.
1982
Regional coronary artery dilation response in variant angina.
American heart journal. 104(2 Pt 1):226-33 [PMID] 6808817.
1982
Regional coronary hemodynamic responses to cold stimulation in patients without variant angina.
The American journal of cardiology. 49(4):665-73 [PMID] 7064816.
1982
Short- and long-term responses to diltiazem in patients with variant angina.
The American journal of cardiology. 49(3):554-9 [PMID] 7036708.
1982
Variability of electrocardiographic responses to repeated ergonovine provocation in variant angina patients with coronary artery spasm.
American heart journal. 103(2):161-7 [PMID] 7055051.
1981
A new temporary atrial pacing catheter inserted percutaneously into the subclavian vein without fluoroscopy: a preliminary report.
Pacing and clinical electrophysiology : PACE. 4(4):458-64 [PMID] 6167965.
1981
Acute effect of intravenous dipyridamole on regional coronary hemodynamics and metabolism.
Circulation. 64(2):333-44 [PMID] 7249300.
1981
Calcium blockers in coronary heart disease. Part I.
Modern concepts of cardiovascular disease. 50(11):61-6 [PMID] 7311967.
1981
Calcium blockers in coronary heart disease. Part II.
Modern concepts of cardiovascular disease. 50(12):67-72 [PMID] 7339485.
1981
Coronary hemodynamic findings during spontaneous angina in patients with variant angina.
Circulation. 64(1):76-83 [PMID] 7237729.
1981
Echocardiographic analysis of systolic and diastolic left ventricular wall motion during transient myocardial ischemia.
Journal of clinical ultrasound : JCU. 9(2):59-65 [PMID] 6782130.
1981
Effect of diltiazem in patients with variant angina: a randomized double-blind trial.
American heart journal. 101(6):719-25 [PMID] 6786067.
1981
Effects of prostacyclin on systemic and coronary hemodynamics in the dog.
American heart journal. 102(5):835-40 [PMID] 7030040.
1981
Influence of the normal human forearm vascular bed on platelet aggregation, counts, size.
Microvascular research. 21(2):229-33 [PMID] 7219202.
1981
Magnitude of dilatation of large and small coronary arteries of nitroglycerin.
Circulation. 64(2):324-33 [PMID] 6788401.
1981
Pathogenesis and pathophysiology of ischemic heart disease.
Annals of the Academy of Medicine, Singapore. 10(4 Suppl):52-8 [PMID] 7344602.
1981
Platelet function studies in coronary artery disease. X. Effect of dipyridamole.
The American journal of cardiology. 47(5):1111-4 [PMID] 7013461.
1981
Quantitation of aortic insufficiency using a catheter-tip velocity transducer.
Circulation. 64(2):375-80 [PMID] 7249305.
1981
Regional coronary angiographic observations during cold stimulation in patient with exertional chest pain: comparison of diameter responses in normal and fixed stenotic vessels.
American heart journal. 102(5):822-30 [PMID] 7304392.
1981
Short-term efficacy of oral verapamil in rest angina. A double-blind placebo controlled trial in CCU patients.
The American journal of medicine. 71(6):977-82 [PMID] 7032291.
1980
Acute haemodynamic effects of oral prazosin in severe mitral regurgitation.
British heart journal. 43(5):556-60 [PMID] 7378216.
1980
Effect of graded narrowing of left main coronary artery on left ventricular function.
The Journal of thoracic and cardiovascular surgery. 79(6):904-10 [PMID] 7374210.
1980
Effects of transient regional ischemia on left ventricular diastolic function.
Journal of clinical ultrasound : JCU. 8(3):233-8 [PMID] 6769963.
1980
Evaluation of a new catheter-mounted electromagnetic velocity sensor during cardiac catheterization.
Catheterization and cardiovascular diagnosis. 6(1):97-113 [PMID] 6988082.
1980
Platelet function studies in coronary artery disease. VII. Effect of aspirin and tachycardia stress on aortic and coronary venous blood.
The American journal of cardiology. 45(5):945-51 [PMID] 7369144.
1980
Recommendations for use of ergonovine to provoke coronary artery spasm.
Catheterization and cardiovascular diagnosis. 6(4):423-6 [PMID] 6781755.
1980
Regional coronary hemodynamic effects of ergonovine in patients with and without variant angina.
Circulation. 62(1):149-59 [PMID] 7379277.
1980
Transluminal coronary angioplasty.
JAMA. 244(17):1966-9 [PMID] 7420711.
1980
Use of catheter-tip velocity–pressure transducer to evaluate left ventricular function in man: effects of intravenous propranolol.
Circulation. 61(5):946-54 [PMID] 7363437.
1980
Use of vasodilators in congestive heart failure.
Advances in cardiology. 27:313-21 [PMID] 6778088.
1980
Vascular load defined by the aortic input impedance spectrum.
Federation proceedings. 39(2):196-201 [PMID] 7353677.
1979
Angiographic definition of critical coronary artery stenosis.
Advances in cardiology. 26:100-9 [PMID] 105566.
1979
Aortic input impedance during nitroprusside infusion. A reconsideration of afterload reduction and beneficial action.
The Journal of clinical investigation. 64(2):643-54 [PMID] 457874.
1979
Aortocoronary sinus anastomosis: a postoperative follow-up 24 years later.
American heart journal. 97(5):631-4 [PMID] 312003.
1979
Clinical use of provocative pharmacoangiography in patients with chest pain.
Advances in cardiology. 26:44-54 [PMID] 420061.
1979
Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
British heart journal. 42(6):664-70 [PMID] 534583.
1979
Coronary arterial responses to graded doses of nitroglycerin.
The American journal of cardiology. 43(1):91-7 [PMID] 103421.
1979
Coronary artery spasm: an important mechanism in the pathophysiology of ischemic heart disease.
Current problems in cardiology. 4(4):1-70 [PMID] 540528.
1979
Demonstration of an inadvertently created aorto-coronary venous anastomosis: evidence against the clinical effectiveness of retrograde coronary venous perfusion.
Catheterization and cardiovascular diagnosis. 5(4):367-70 [PMID] 527039.
1979
Diagnostic tests for tricuspid insufficiency: how good?
Catheterization and cardiovascular diagnosis. 5(1):1-6 [PMID] 378388.
1979
Effects of the Valsalva maneuver on myocardial ischemia in patients with coronary artery disease.
Circulation. 59(6):1304-11 [PMID] 436222.
1979
Influence of aortic insufficiency on the hemodynamic significance of a coronary artery narrowing.
Circulation. 60(2):259-68 [PMID] 156092.
1979
Initial medical and surgical management of unstable angina pectoris.
Clinical cardiology. 2(5):311-6 [PMID] 399449.
1979
Instantaneous blood flow responses to positive end-expiratory pressure with spontaneous ventilation.
Circulation. 59(6):1312-8 [PMID] 373924.
1979
Intracardiac M-mode echocardiography for continuous left ventricular monitoring: method and potential application.
Catheterization and cardiovascular diagnosis. 5(2):135-43 [PMID] 487417.
1979
Left main coronary artery stenosis: clinical spectrum, pathophysiology, and management.
Progress in cardiovascular diseases. 22(2):73-106 [PMID] 384459.
1979
Platelet aggregation across the myocardial vascular bed in man: I. Normal versus diseased coronary arteries.
Thrombosis research. 14(2-3):423-32 [PMID] 442015.
1979
Quantitative coronary arteriography using 105-MM photospot angiography and an optical magnifying device.
Catheterization and cardiovascular diagnosis. 5(2):195-201 [PMID] 487424.
1979
Similarities of ergonovine-induced and spontaneous attacks of variant angina.
Circulation. 59(2):307-12 [PMID] 103658.
1979
The coronary hemodynamics of left main and branch coronary stenoses. The effects of reduction in stenosis diameter, stenosis length, and number of stenoses.
The Journal of thoracic and cardiovascular surgery. 77(3):377-88 [PMID] 762981.
1978
Aneurysm of sinus of Valsalva: cause of dynamic coronary constriction after aortic valvular replacement and bacterial endocarditis.
Chest. 74(3):312-4 [PMID] 688794.
1978
Aortic input impedance in heart failure.
Circulation. 58(3 Pt 1):460-5 [PMID] 679436.
1978
Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
The American journal of cardiology. 41(5):925-30 [PMID] 645603.
1978
Coronary and myocardial metabolic effects of combined glyceryl trinitrate and propranolol administration. Observations in patients with and without coronary disease.
British heart journal. 40(11):1221-8 [PMID] 102330.
1978
Differences in platelet aggregation in coronary sinus and aortic blood in patients with coronary artery disease: effect of propranolol.
Clinical cardiology. 1(2):96-100 [PMID] 756822.
1978
Effect of sublingual nitroglycerin on regional flow in patients with and without coronary disease.
Circulation. 58(5):803-7 [PMID] 100259.
1978
Ergonovine testing for coronary artery spasm in patients with angiographic mitral valve prolapse.
Catheterization and cardiovascular diagnosis. 4(3):265-74 [PMID] 737730.
1978
Estimation of beat-to-beat stroke volume from the pulmonary arterial pressure contour in man.
Medical & biological engineering & computing. 16(6):707-14 [PMID] 310932.
1978
Haemodynamic effects of hydrallazine and of hydrallazine plus glyceryl trinitrate paste in heart failure.
British heart journal. 40(8):845-50 [PMID] 99155.
1978
Hemodynamic and myocardial metabolic effects of ergonovine in patients with chest pain.
Circulation. 58(4):648-54 [PMID] 688575.
1978
Hemodynamic effects of long and multiple coronary arterial narrowings.
Chest. 74(3):280-5 [PMID] 688785.
1978
Hemodynamic significance of the length of a coronary arterial narrowing.
The American journal of cardiology. 41(5):865-71 [PMID] 645594.
1978
In vivo validation of a thermodilution method to determine regional left ventricular blood flow in patients with coronary disease.
Circulation. 58(5):795-802 [PMID] 151608.
1978
Non-parenteral combined afterload and preload reduction therapy in congestive heart failure.
Clinical cardiology. 1(2):68-73 [PMID] 116791.
1978
Percutaneous left ventricular catheterisation with an ultraminiature catheter-tip pressure transducer.
Cardiovascular research. 12(9):566-8 [PMID] 737669.
1978
Platelet aggregation in aortic and coronary venous blood in patients with and without coronary disease. 3. Role of tachycardia stress and propranolol.
Circulation. 58(5):881-6 [PMID] 699254.
1978
Platelet aggregation studies in coronary artery disease. Past 4. Effect of aspirin.
Atherosclerosis. 31(2):169-75 [PMID] 728235.
1978
Pulsatile flow characteristics of aortic valve porcine heterografts in man.
Circulation. 58(3 Pt 2):I162-5 [PMID] 14740697.
1978
The angiographic definition of critical coronary stenosis.
Acta medica Scandinavica. Supplementum. 615:9-17 [PMID] 99986.
1978
Unusual vasomotor coronary arterial responses after nitroglycerin.
The American journal of cardiology. 42(3):517-9 [PMID] 99020.
1977
Coronary circulatory effects of increased intrathoracic pressure in intact dogs.
Chest. 72(1):72-8 [PMID] 872658.
1977
Effects of ergonovine in patients with and without coronary artery disease.
Circulation. 56(5):803-9 [PMID] 912842.
1977
Effects of propranolol on coronary hemodynamic and metabolic responses to tachycardia stress in patients with and without coronary disease.
Catheterization and cardiovascular diagnosis. 3(1):47-57 [PMID] 837433.
1977
Instantaneous force-velocity-length relations in the intact human heart.
The American journal of cardiology. 40(5):754-61 [PMID] 920612.
1977
Transient asymptomatic S-T segment depression during daily activity.
The American journal of cardiology. 39(3):396-402 [PMID] 402803.
1976
Diagnosis of aortic valvular prolapse by echocardiography.
Chest. 69(3):411-3 [PMID] 971612.
1975
Anomalous coronary artery origin and bicuspid aortic valve.
Vascular surgery. 9(2):67-72 [PMID] 1130136.
1974
Effects of perhexiline on coronary hemodynamic and myocardial metabolic responses to tachycardia.
Circulation. 49(5):887-93 [PMID] 4828610.
1973
Effects of perhexiline on left ventricular responses to exercise and atrial pacing.
Arquivos brasileiros de cardiologia. 26 Suppl 1:97-103 [PMID] 4787500.
1973
Hyperkinetic cardiovascular state in polymyositis.
Chest. 64(2):243-6 [PMID] 4146837.
1973
Long-term observations in patients with angina and normal coronary arteriograms.
Circulation. 47(1):36-43 [PMID] 4686602.
1973
Proceedings: Alteration of left ventricular responses to ischemia with oral perhexiline.
Postgraduate medical journal. 49:Suppl 3:43-6 [PMID] 4587031.
1972
Angiographic diagnosis of coronary artery lacerations.
The Journal of thoracic and cardiovascular surgery. 63(2):183-4 [PMID] 5009727.
1972
Relationship of anginal symptoms to lung mechanics during myocardial ischemia.
Circulation. 46(5):863-9 [PMID] 4628188.
1970
Heart muscle disease in acromegaly.
The American journal of medicine. 48(4):530-4 [PMID] 4192145.
1964
SHEAR AND PEARSE METHOD FOR DIRECT HISTOCHEMICAL DEMONSTRATION OF SIALIC ACID.
Nature. 201:630-1 [PMID] 14160667.
Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial (Preprint)
. [DOI] 10.2196/preprints.8057.

Grants

Mar 2024 ACTIVE
Magnetocardiography as a Noninvasive Diagnostic Strategy for Suspected Myocardial Ischemia With the Absence of Obstructive Coronary Artery Disease As Confirmed by Thermodilution-Derived CFR
Role: Principal Investigator
Funding: GENETESIS
Jan 2024 ACTIVE
Isha Therapeutics LLC Funded Consulting Agreement
Role: Principal Investigator
Funding: ISHA THERAPEUTICS
Aug 2023 ACTIVE
Bloomer Augmented Garment Platform-Barrier Removal for women in cArdiac rehab (BRA)
Role: Principal Investigator
Funding: BLOOMER HEALTH TECH via NATL INST OF HLTH
Jul 2023 ACTIVE
QUantifIEd Coronary Artery Plaque and OuTcomes (QUIET): WARRIOR Ancillary Study
Role: Principal Investigator
Funding: US ARMY MED RES ACQUISITION
Jun 2023 ACTIVE
High Intensity Interval Training: Optimizing Exercise Therapy to Mitigate Cardiovascular Disease Risk Following Breast Cancer Chemotherapy
Role: Co-Investigator
Funding: NATL INST OF HLTH NIA
Apr 2023 ACTIVE
EVOLVE-MI: A Pragmatic Randomized Multicenter Trial of EVOLocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized With Acute Myocardial Infarction
Role: Principal Investigator
Funding: COLORADO PREVENTION CTR dba CPC CLINICAL via AMGEN INC
Oct 2022 ACTIVE
Engaging underrepresented populations in cardiovascular disease trials to help reduce disparate outcomes
Role: Other
Funding: BRISTOL-MYERS SQUIBB FOUNDATION
Aug 2022 ACTIVE
High-throughput screening for antihypertensive prescribing cascades
Role: Co-Investigator
Funding: NATL INST OF HLTH NHLBI
Jul 2022 – Feb 2024
Microvascular Disease Burden and Cerebral Small Vessel Disease: Relations to Neurocognition
Role: Principal Investigator
Funding: CEDARS SINAI MEDICAL CTR via NATL INST OF HLTH NHLBI
Jul 2022 – Jun 2023
Risk of adverse cardiovascular events in breast cancer patients receiving systemic adjuvant therapy: impact of comorbidity burden
Role: Co-Investigator
Funding: FL BREAST CANCER FOU
Jun 2022 ACTIVE
Genetic Associations of Ischemic Heart Disease and Symptoms Among Diverse Postmenopausal Women
Role: Co-Investigator
Funding: NATL INST OF HLTH NIA
Apr 2022 – Aug 2022
Enhancing evidence generation by linking randomized clinical trials (RCTs) to real world data (RWD)
Role: Principal Investigator
Funding: BRIGHAM AND WOMENS HOSPITAL via US FOOD AND DRUG ADMN
Sep 2021 ACTIVE
Alcohol-Associated Syndemic and Microbiome Evaluation and Targeted Treatment in Persons Living with HIV
Role: Other
Funding: NATL INST OF HLTH NIAAA
Jul 2021 ACTIVE
Myocardial Steatosis in Women with Coronary Microvascular Dysfunction: Defining the Pathway to Heart Failure with Preserved Ejection Fraction (HFpEF)
Role: Principal Investigator
Funding: CEDARS SINAI MEDICAL CTR via NATL INST OF HLTH NHLBI
Jun 2021 ACTIVE
All-Extremity Exercise as a Novel Strategy for Optimizing Cardiovascular Function during Chemotherapy for Breast Cancer
Role: Co-Investigator
Funding: NATL INST OF HLTH NHLBI
Jun 2021 – Jun 2022
Neural mechanisms of host-microbiota interaction in hypertension: a potential for bio-electronic medicine
Role: Co-Investigator
Funding: UNIV OF TOLEDO via NATL INST OF HLTH NHLBI
May 2021 – Oct 2022
Preventing the Calcium Channel Blocker Lower Extremity Edema Loop Diuretic Prescribing Cascade in Older Adults
Role: Other
Funding: NATL INST OF HLTH NIA
Apr 2021 – Dec 2022
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)
Role: Principal Investigator
Funding: BRIGHAM AND WOMENS HOSPITAL
Jul 2020 ACTIVE
The Microvascular Aging and Eicosanoids Womens Evaluation of Systemic aging Tenacity (MAE-WEST) Specialized Center of Research Excellence (SCORE) on Sex Differences
Role: Principal Investigator
Funding: CEDARS SINAI MEDICAL CTR via NATL INST OF HLTH NIA
Sep 2019 ACTIVE
Sex Differences in Chronic and Acute Vascular Responses to Aerobic Exercise in Older Adults
Role: Co-Investigator
Funding: NATL INST OF HLTH NIA
May 2019 – Feb 2024
Womens Ischemia Syndrome Evaluation (WISE) Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)
Role: Principal Investigator
Funding: CEDARS SINAI MEDICAL CTR via NATL INST OF HLTH NHLBI
Mar 2019 – Mar 2024
A Phase 3, OpenLabel, Multicentre Study of Flurpiridaz (18F) Injection for Positron Emission Tomography (PET) Imaging for Assessment of Myocardial Perfusion in Patients Referred for Invasive Coronary Angiography Because of Suspected Coronary Artery Disease
Role: Principal Investigator
Funding: PPD INVESTIGATOR SERVICES LLC via GE Healthcare
Oct 2018 ACTIVE
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome
Role: Principal Investigator
Funding: CSL BEHRING
Jul 2018 – Jun 2023
Advancing Personalized Hypertension Care through Big Data Science
Role: Other
Funding: NATL INST OF HLTH NHLBI
Jun 2018 – May 2021
OR-DRPD-ROF2018: Perfusable Magnetic Cryoprotecting Agents for Heart Biobanking
Role: Co-Investigator
Funding: UF RESEARCH
Jan 2018 – Oct 2022
A randomized, double-blind, placebo-controlled parallel arm dose titration study to assess the effects of SAR407899 in patients with microvascular angina and/or persistent stable angina despite angiographically successful elective percutaneous coronary intervention
Role: Principal Investigator
Funding: SANOFI US SERVICES
Sep 2017 ACTIVE
Women's Ischemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR)
Role: Principal Investigator
Funding: US ARMY MED RES ACQUISITION
Apr 2017 – Jun 2021
OoR CTSI Institutional Matching Support
Role: Project Manager
Funding: UF DIV OF SPONSORED RES MATCHING FUNDS
Oct 2016 – Feb 2023
Qualitative interviews to understand the patient experience of Microvascular Angina (MVA)
Role: Principal Investigator
Funding: ADELPHI VALUES
Sep 2016 – Jun 2021
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)
Role: Co-Investigator
Funding: DUKE UNIVERSITY via PATIENT-CENTERED OUTCOMES RES INST
Sep 2016 – Jan 2022
Vascular Smooth Muscle Lysyl Oxidase Mediated Increase in Vessel Stiffness and its Effect on Rho-Kinase Mechanosensors: A Novel Mechanism of Atherosclerosis in Chronic Kidney Disease?
Role: Other
Funding: NATL INST OF HLTH NHLBI
Sep 2016 – Aug 2018
STOP HEART DISEASE
Role: Principal Investigator
Funding: FL HEART RESEARCH FOU
May 2016 – Jun 2023
A DOUBLE-BLIND, RANDOMIZED, SHAMPROCEDURECONTROLLED, PARALLEL-GROUP EFFICACY AND SAFETY STUDY OF ALLOGENEIC
Role: Principal Investigator
Funding: INVENTIV HEALTH CLINICAL LLC via MESOBLAST INC
May 2016 – Oct 2022
A RANDOMIZED, DOUBLE-BLIN, PLACEBO CONTROLLED, PARALLEL- GROUP STUDY TO EVALUATE THE EFFECT OF SAR236553/REGN727
Role: Principal Investigator
Funding: SANOFI US SERVICES
May 2016 – Dec 2018
ADIPOSE-DERIVED REGENERATIVE CELLS IN THE TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE NOT AMENABLE…
Role: Principal Investigator
Funding: CYTORI THERAPEUTICS
Apr 2016 – Sep 2021
Brain-Gut Microbiome-Immune Axis in Hypertension
Role: Project Manager
Funding: NATL INST OF HLTH NHLBI
Feb 2016 – Sep 2019
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)
Role: Principal Investigator
Funding: BRIGHAM AND WOMENS HOSPITAL via NATL INST OF HLTH NHLBI
Oct 2015 – Mar 2019
OneFlorida Clinical Research Consortium Phase II
Role: Project Manager
Funding: PATIENT-CENTERED OUTCOMES RES INST
Mar 2015 – Mar 2018
A Phase 2 prospective, randomized, double-blind, sham-controlled, parallel-group, multi-center trial of AMI MultiStem? in subjects with non-ST elevation acute myocardial infarction (NSTEMI)
Role: Principal Investigator
Funding: ABT HOLDING COMPANY
Apr 2014 – Dec 2016
ALLSTAR (ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration)
Role: Principal Investigator
Funding: CAPRICOR, INC.
Apr 2014 – Mar 2017
A Double-blind, Randomized, Shamprocedurecontrolled, Parallel-group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (CEP41750) in Patients with Chronic Heart Failure Due to Left Ventricular Systolic Dysfunction of Either Ischemic
Role: Principal Investigator
Funding: MESOBLAST INC via MESOBLAST INC
Dec 2013 ACTIVE
PEPINE PAYROLL OPERATING ACCOUNT
Role: Principal Investigator
Funding: 214 OPERATING ACCOUNT
Jul 2013 – May 2019
Angiotensin and neuroimmune activation in hypertension
Role: Project Manager
Funding: NATL INST OF HLTH NHLBI
May 2013 – May 2016
Characterization of Adipose Derived Regenerative Cells (ADRCs) from excess tissue and cells designated for discard from patients with chronic heart disease
Role: Principal Investigator
Funding: CYTORI THERAPEUTICS
Dec 2012 – Dec 2018
Adipose-Derived Regenerative Cells in the Treatment of Patients with Chronic Ischemic Heart Disease Not Amenable to Surgical or Interventional Revascularization
Role: Principal Investigator
Funding: CYTORI THERAPEUTICS
Dec 2012 – Dec 2018
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome
Role: Principal Investigator
Funding: SANOFI US SERVICES
Mar 2012 – Mar 2016
A prospective, randomized, double-blinded, active-control and unblindedstandard of care (SOC) controlled study to determine the efficacy and safety oftargeted intramyocardial delivery of autologous CD34+ cells (Auto-CD34+cells) for increasing exerc
Role: Principal Investigator
Funding: PPD DEVELOPMENT via BAXTER HEALTHCARE CORP
Mar 2012 – Aug 2020
CCTRN-2 Time, Late Time, and Focus
Role: Principal Investigator
Funding: UNIV OF TEXAS HLTH SCI CTR AT HOUSTON via NATL INST OF HLTH NHLBI
Mar 2012 – Aug 2020
UFRCC for Cardiovascular Cell Therapy Research Network
Role: Principal Investigator
Funding: NATL INST OF HLTH NHLBI
Feb 2012 – May 2017
A Prospective Randomized Double Blinded Placebo Controlled Phase II Trial of Intra-coronary Infusion of AMR-001, a Bone Marrow Derived Autologous CD34+ Selected Cell Product, in Patients with Acute Myocardial Infarction
Role: Principal Investigator
Funding: AMORCYTE
Sep 2011 – Nov 2018
The LIFE Study
Role: Project Manager
Funding: NATL INST OF HLTH NIA
Aug 2011 – Aug 2020
Treatment with Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina and Myocardial Ischemia
Role: Principal Investigator
Funding: CEDARS SINAI MEDICAL CTR via GILEAD SCIENCES
Aug 2010 – Jul 2017
Pharmacogenomic Evaluation of Antihypertensive Responses.
Role: Project Manager
Funding: NATL INST OF HLTH NIGMS
Jul 2010 – Jun 2016
Chemometric Observations of Lipid Core Containing Plaques of Interest in Native Coronary Arteries (COLOR) Registry
Role: Principal Investigator
Funding: INFRAREDX
Aug 2001 – Aug 2016
01081606
Role: Principal Investigator
Funding: PFIZER INC PHARMACEUTICALS

Education

Fellowship – Cardiopulmonary Physiology
1969-1971 · Naval Hospital and Thomas Jefferson University
Residency – Internal Medicine
1968-1969 · Naval Hospital
Residency – Internal Medicine
1967-1968 · Thomas Jefferson University
Internship – Internal Medicine
1966-1967 · Allegheny University Hospital
Medical Degree
1962-1966 · Rutgers University
BS in Psychology/Undergraduate in Pre-Medical
1959-1962 · University of Pittsburgh

Contact Details

Phones:
Business:
(352) 273-9082
Emails:
Addresses:
Business Mailing:
PO Box 100288
GAINESVILLE FL 32610
Business Street:
Box 100288
1329 Building
1329 SW 16th Street
GAINESVILLE FL 326100288